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Current virus inactivation strategies are working toward targeted inhibition of viral 
replication machinery by antiviral drugs. In addition, vaccination is another widely used 
strategy. However, the genetic and serological heterogeneities of viruses hamper the 
development of effective vaccines or antiviral drugs that work against all viruses of different 
serotypes and strains. Meanwhile, viruses that mutate rapidly will render the vaccines or 
antiviral drugs to be ineffective. 
 
An alternative strategy in virus inactivation can be achieved through a light-based approach 
called photodynamic therapy (PDT). This approach requires the excitation of light-sensitive 
materials called photosensitizers to produce reactive oxygen species which mediate the 
inactivation of viruses. PDT results in the direct inactivation of viruses without depending on 
the host-virus responses. Although photodynamic effect has been demonstrated against 
viruses, it has been slow in gaining acceptance, mainly because of the hydrophobicity of 
photosentizers and current light sources used, which have limited tissue penetration ability.  
 
Here, we report a novel upconversion nanoparticle-based PDT to photodynamically 
inactivate viruses. In this strategy, photosensitizers are loaded onto the near-infrared (NIR)-
to-visible upconversion nanoparticles (UCNs). When the nanoparticles are irradiated with 
NIR light at 980 nm, the UCNs emit visible light which is being absorbed by the 
photosensitizers. The excited photosensitizers then convert nearby molecular oxygen to toxic 
singlet oxygen species, which mediate viral inactivation. The UCNs act as nanocarriers of the 
highly hydrophobic photosensitizers as well as nanotransducers that convert NIR light to 
visible emissions necessary for the excitation of photosensitizers. The use of NIR light 
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introduces several advantages such as high light penetration depth in vivo and minimal 
photodamage to cells and tissues. 
 
The synthesized UCNs emit strong upconversion fluorescence by producing visible emissions 
in the green and red regions with peaks at 545 nm and 658 nm respectively when the UCNs 
were being irradiated with NIR light at 980 nm. ZnPc was used as the photosensitizer in this 
work due to its high absorption coefficient and quantum yields. Singlet oxygen is consistently 
being released from the UCNs over time. Using both PEI-coated and mesoporous silica-
coated UCNs, we observed a significant decrease in virus titers when the Dengue viruses 
were irradiated in the presence of UCNs, demonstrating the feasibility of UCN-based system 
for photodynamic inactivation of viruses. In another development, NIR light was shown to 
penetrate mouse tissues and photodynamic inactivation of viruses beneath the skin tissues 
was achieved.  
 
The findings from this work demonstrate the feasibility of UCN-based PDT to 
photodynamically inactivate viruses with advantages over current PDT technique. Moreover, 
it further realizes the potential of utilizing this strategy in treating localized viral infections, 
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Chapter 1: Introduction 
1.1 Overview to viruses 
 
Virus is an infectious particle which replicates inside the host cells but remains metabolically 
inert outside the cells. The genetic material is made up of nucleic acids and may exist as 
deoxyribonucleic acids (DNA) or ribonucleic acids (RNA). These genes are protected by a 
protein coat called capsid. Some viruses have a lipid bilayer envelope with glycoproteins on 
the surface of the envelope. The viral envelopes play an important role in mediating the entry 
of viruses into the host organism. Viruses exist in various sizes and shapes which include 
helical, polyhedral, enveloped and binal. 
 
Viruses transmit from one host organism to another via exchange of bodily fluid, airborne 
route, waterborne route or fecal-oral route. Upon entry into a host organism, such as human, a 
virus is activated and by intervening and utilizations of the host cells’ metabolic machinery, 
the virus starts to replicate. During the virus replication cycle, the host cell undergoes 
cytopathic changes, which may activate the body’s immune system or disrupt the body’s 
physiology, eventually causing symptoms such as fever, flu, to swelling of blood vessels and 
gastrological disorder. In cases of severity, virus infection may lead to death when left 
untreated. 
 
Infectious diseases caused by viruses are many and some of the serious diseases include 
acquired immune deficiency syndrome (AIDS), severe acute respiratory syndrome (SARS) 
and influenza. The spread of SARS and H1N1 swine flu pandemic recently was a public 
health emergency of international concern. Thus, despite their minuteness, viruses pose huge 
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life threats and economic lost which raise concerns of viruses as medically important 
pathogens in the 21
st
 century. 
1.2 Current virus inactivation strategies 
 
Vaccination and antiviral drugs are currently the two clinically-adopted antiviral strategies. 
Although vaccination is capable of providing immunity when the person is still healthy, it is 
not effective against already-infected patients. In addition, viruses with high mutation rates 
such as influenza cause vaccines to be ineffective. There is also the possibility that the 
vaccines could harm the host by unintentional infection to the host. Due to its systemic 
immunity nature, vaccinations cannot be deployed to prevent virus infection at the localized 
level.   
 
As for antiviral drugs which inactivate viruses based on targeted inhibition of virus 
replication machinery, the efficacy of the drugs is very much limited by genetic and 
serological heterogeneities of viruses. One example is the difficulty in developing an antiviral 
drug that is effective against all four serotypes of Dengue virus due to the differences 
between serotypes. Moreover, the toxicity and side effects of the antiviral drugs pose another 
major concern for the infected patients. Meanwhile, viruses that undergo high mutation rates 
like the influenza virus will render the newly developed drugs to be ineffective within few 
years. Along with vaccinations, antiviral drugs could not be used to treat localized virus 






1.3 Photodynamic therapy (PDT): An alternative 
 
PDT works via the excitation of light-sensitive materials called photosensitizers to produce 
reactive oxygen species (ROS) which mediate the inactivation of viruses. PDT inactivates 
viruses directly compared to vaccinations and antiviral drugs which depend on host-virus 
interactions. Hence, PDT offers an attractive alternative for the development of a potential 
antiviral strategy with therapeutical applications.  
 
At present, the main therapeutic application for PDT is in the field of cancer [1, 2]. Although 
PDT is mainly applied for cancer therapy, it has been adopted to treat various non-
oncological diseases as well. PDT has been reported to be effective against various bacterial, 
fungal and protozoan pathogens [3]. In fact, photodynamic processes in medicine was first 
demonstrated through the inactivation of a microorganism (Paramecium caudatum) from the 
lethal effect of acridine and visible light [4]. 
 
Although photodynamic effect has long been demonstrated against viral targets, the path 
leading to it being adopted clinically for treatment of viral diseases remains challenging with 
many hurdles  [5]. Various problems with PDT such as impure photosensitizers, unspecific 
light sources and irregular dosimetry have slowed its adoption in mainstream medicine [6].  
 
Common photosensitizers that have been employed to date in the photodynamic inactivation 
of viruses are dyes or its associated derivatives [7]. Usually, ultraviolet (UV) or visible light 
is used to excite the photosensitizers. However, these light sources have serious drawbacks, 
which include limited tissue penetration and dangerous carcinogenic and cytotoxic effects. In 
addition, cell pigmentation generally absorbs strongly in the visible light region . As most of 
the photosensitizers also absorb within this range, light energy delivered to the target site is 
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much reduced due to competitive absorption by the cell pigmentation. Moreover, the majority 
of photosensitizers aggregate easily in aqueous media due to their hydrophobicity. This 
results in altered chemical and biological properties.  
 
1.4 Motivations and Objectives 
 
Nanotechnology has contributed rapidly to the development of novel materials with excellent 
properties and functionalities. One particular example is the ultrafine particles called 
nanoparticles. Nanoparticles can be created from various materials and further fine tuned to 
deliver unique surface properties, leading to their rapid deployment in biomedicine. [8]. As 
photosensitizer carriers, nanoparticles show great promise in advancing the field of PDT and 
overcoming the associated limitations. 
 
The objective of this project was to use upconversion nanoparticles for the development of 
upconversion nanoparticle-based photodynamic inactivation strategy. In order to achieve this 
objective, the following specific aims should be accomplished: 
 
Synthesis of upconversion nanoparticles and ZnPc incorporation: Upconversion 





) were synthesized based on a hydrothermal method. Due to the surface 
properties, the synthesized nanoparticles were not soluble in water. To confer hydrophilicity, 
the nanoparticles were coated with a layer of polyethylenimine (PEI). PEI is a polymer with 
amino functional groups that renders nanoparticles hydrophilic. Zinc (II) phthalocyanine 
(ZnPc) photosensitizers were attached to the PEI coating via physical adsorption. In another 
design, the nanoparticles were first coated with a thin layer of silica followed by subsequent 
mesoporous silica coating which the ZnPc was later incorporated. 
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Photodynamic inactivation of viruses in suspension using the ZnPc-loaded nanoparticles: 
The UCNs were studied for their potential use in the development of UCN-based 
photodynamic inactivation system against viruses. For this purpose, Dengue virus serotype 2 
(DENV2), an enveloped RNA virus, was used. To the best of our knowledge, the idea of 
nanoparticle-based photodynamic inactivation is novel and has not been reported elsewhere. 
The localized nature of PDT is best suited to treat viruses causing topical infections such as 
herpesvirus and papillomavirus. However, due to unavailability of the source, Dengue virus 
was used instead as an alternative model in this study. Hence, we wish to highlight here that 
it was never the objective of this study to develop the UCN-based photodynamic inactivation 
strategy for the treatment of Dengue virus infections such as Dengue hemorrhagic fever. The 
DENV2 merely acted as a virus model for this proof-of-concept study. Photodynamic 
inactivation of viruses in suspension was first carried out to assess the feasibility and efficacy 
of inactivating extracellular viruses using these nanoparticles. The photodynamic inactivation 
ability of the nanoparticles was studied with various parameters such as light fluence and 
nanoparticle concentration. Photodynamic inactivation of virus suspensions in the presence of 
mouse tissues was also performed to demonstrate the tissue penetration ability of near 










1.5 Thesis overview 
 
This thesis consists of 6 chapters and the organization of the thesis is as follows: 
Chapter 1: Provides background information about current virus inactivation strategies and a 
closer look at PDT as an alternative.  
Chapter 2: Presents the literature review of PDT and upconversion nanoparticles.  
Chapter 3: Explores the use of PEI-coated UCNs for the photodynamic inactivation of 
viruses in suspension.  
Chapter 4: Discusses the synthesis and characterizations of the mesoporous silica-coated 
UCNs.  
Chapter 5: Presents the capability of mesoporous silica-coated UCNs to photodynamically 
inactivate viruses in suspension and the ability of NIR light to penetrate mouse tissues and 
inactivate viruses beneath the tissues.  
Chapter 6: Summarizes the work done thus far of this project and provides key 




Chapter 2: Literature Review 
2.1 Photodynamic therapy (PDT)  
 
PDT is an oxygen-dependent therapy which produces toxic reactive oxygen species (ROS) by 
light-activable photosensitizers. This oxygen-dependency distinguishes PDT from other types 
of photochemotherapy [9].  
 
2.1.1 Mechanism of PDT  
 
The mechanism of PDT can be divided into three stages, namely photosensitizer excitation, 
ROS production and cell death. Light emitting the suitable wavelength is employed to excite 
the photosensitizer. A particular light source is chosen such that its emission spectrum 
overlaps well with the absorption spectrum of the photosensitizer. When the photosensitizer 
absorbs light with appropriate wavelength, it is elevated electronically from ground state to 
excited state [10]. Excitation of the photosensitizers leads to either type I or type II reaction, 
resulting in ROS generation (Figure 2.1).  
 
In type I reaction, the excited photosensitizers transfer their energy to a substrate, normally 
cell membrane or a molecule, which subsequently reacts with oxygen. On the other hand, the 
excited photosensitizers can also transfer their energy directly to the surrounding oxygen 
molecules (type II reaction). For type I reaction, the energy transfer between the 
photosensitizers and substrates generates reactive free radicals which react with oxygen  and 
produces hydroxyl radicals, superoxide anion radicals and hydrogen peroxides [11]. 
Meanwhile, type II reaction which is commonly regarded as the dominant reaction produces 




Figure 2.1 The light-excited photosensitizers can go through either type I or type II reaction, 
both of which eventually result in the production of ROS. (Reproduced with permission from 




O2), can be produced through the interaction of ground state oxygen (
3
O2) 
with the excited photosensitizer molecule (P*):  
             P +
 
light  P*            
             P* + 
3
O2  P + 
1
O2        
1
O2 species has a very short lifetime (> 3.5 µs) and diffuses only 0.01 to 0.02 µm due to [13, 
14]. As such, the damage causes by 
1
O2 is bound to the immediate surroundings of the 
photosensitizers which have been exposed to light. This property of 
1
O2 prevents it from 
interacting with distant targets, at the same time increasing its specificity [15]. Multiple 
regeneration of the 
1
O2 species could occur due to the short lifespan of 
1
O2, thus allowing 
consistent photodynamic actions within a short time period.   
 
The formation of ROS such as 
1
O2 or free radicals causes the oxidization of various cellular 
compartments such as mitochondria, plasma membrane and Golgi apparatus [16], resulting in 
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the destruction of the treated tissue. Damages to the cellular compartments lead to cell death 
mediated by apoptotic, necrotic or autophagic pathway [17]. Photosensitizers localized to the 
plasma membrane or lysosomes may sometimes block the apoptotic pathway, leading to 
induction of  autophagy or necrosis [18]. Nevertheless, studies have suggested that apoptosis 
is the preferable outcome of PDT [16]. 
 
The above descriptions of the PDT mechanism are cell-based as the PDT of cancer is 
currently gaining clinical acceptance and its mechanism widely studied. However, PDT is 
also extended to the field of microbial infections and virus inactivation. The exact PDT 
mechanism to inactivate viruses is not fully understood. Type II reaction is widely recognized 
as the dominant reaction in causing photodynamic viral damage [7]. The extent of the PDT 
damage on viruses is depending on the chemistry of the photosensitizers used. Nucleic acid 
and viral envelope are the two target sites identified. Majority of the photosensitizers used in 
PDT against viruses, for example methylene blue and psoralens, are causing damage to the 
viral nucleic acid via an intercalative mechanism. Damage to the nucleic acids occurs through 
the oxidation of guanosine residues, leading to DNA or RNA damage [5]. Other 
photosensitizers such as phthalocyanines have been found to damage viral envelopes via 
reaction with phospholipids and peptides. The ROS interact with membrane lipids and 
stimulate lipid peroxidation while interaction with peptides are mainly through cycloaddition 
to tryptophan residues [19]. These reactions with viral envelope result in virus inactivation 






2.1.2 State-of-the-art progress of PDT 
 
A German medical student, Oscar Raab, was first to report in 1900 that the combination of 
light and acridine are cytotoxic to Paramecium caudatum [4]. The term “photodynamic 
action” was introduced by Von Tappeiner and Jesionek in 1903 based on their observations in 
the treatment of skin tumors by applying eosin to the tumor sites in conjunction with white 
light [20]. However, it was only until 1975 when Dougherty and his team reported the 
complete eradication of tumor in mice [21]. This development has led to the interest for PDT 
studies in cancer. Thus far, PDT treatment has been reported clinically on various cancerous 
tumors such as breast cancer tumors, gynecological tumors, head and neck tumors, colorectal 
cancer tumors, cutaneous malignancies, intraperitoneal tumors and pancreatic tumors [22-28]. 
Currently, PDT is recommended for patients with early-stage cancers because the cancers 
could not be operated on. However, in further studies, the effectiveness of PDT has been 
called into question due to issues with specificity and potency of photosenstizers. 
2.2 Photodynamic inactivation of viruses by PDT 
 
In 1928, Schultz et al. first reported the photodynamic inactivation of a virus, Staphylococcus 
bacteriophage using methylene blue [29] but it was only until the 1970s that the first PDT 
clinical trial in humans was first conducted to treat herpes genitalis, genital infection by 
herpes simplex virus [6]. However there were concerns that the neutral red photosensitizer 
converts healthy cells to malignant cells and causes damage to nucleic acids of surrounding 
healthy cells [30]. Subsequently trials were discontinued [31]. In view of all the problems, it 
seems that the use of photosensitizers for PDT treatment of topical vius infection is less 
appealing. Currently, herpes virus and papillomavirus are the two major viruses amenable to 
the photodynamic approach clinically. These two viruses have been the focus of PDT studies 
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on viruses due to their localized nature of infections. PDT has also been actively studied in 
the field of blood product disinfection, which greatly increased the range of susceptible 
viruses.  
  
2.2.1 PDT of herpesvirus infection 
 
The adoption of PDT to treat herpesvirus infection was first demonstrated on herpes genitalis 
and ophthalmic keratitis using neutral red and proflavine photosensitizers, they were shown 
to be effective [32, 33], however side effects were also seen [34]. The side effects for neutral 
red and proflavine photosensitizers have long been acknowledged. Nevertheless, risk of side 
effects increased using photosensitizers which are not pure with unoptimized dosimetry [35] 
coupled with the deployment of short-wavelength light sources [36]. In addition, the use of 
UV light necessary to excite proflavine contributed more damages to the host. Compared to 
the control (without treatment), UV light’s mutation rate was shown to be 15 to 20 times 
higher [37].  
 
2.2.2 PDT of papillomavirus infection 
 
HPD and dihematoporphyrin ether (HPE) were used as the photosensitizers for PDT of 
laryngeal papillomata, an infection caused by human papillomavirus (HPV) [38, 39]. The 
results of this treatment were not encouraging and photosensitization of the skin after 
treatment was regularly seen [40].  
  
In 1999, 5-aminolevulic acid (ALA) received clearance from the Food and Drug 
Administration (FDA) as a medication for localized PDT therapy of nonhypertrophic actinic 
keratoses [41]. ALA is a photosensitizing agent which could penetrate into underlying tissues 
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where it is being converted into protoporphyrin IX (PpIX) photosensitizer. This ALA-PDT 
was reported  to be effective against human immunodeficiency virus (HIV) and herpesvirus 
in vitro and in vivo [42]. In addition, this localized ALA-PDT treatment has also been 
adopted to treat warts such as Verrucae vulgaris and Molluscum contagiosum [43] which are 
caused by papillomavirus and Molluscum contagiosum virus (a human pox virus) 
respectively. However, this therapy yields phototoxic reaction such as pain, stinging, itching, 










Figure 2.2 Phototoxic reaction of ALA-PDT resulting in patients experiencing pain, stinging, 
burning, itching and hyperpigmentation. (Reproduced with permission from Elsevier Limited) 
 
2.2.3 PDT in blood disinfection 
Donated whole blood may be used in direct replacement for blood loss in trauma or surgery, 
or it may be separated physically into a number of useful blood products. To achieve 
sufficient levels of these factors, plasma fractions are concentrated or pooled together. Blood 
plays an important role in transporting oxygen and nutrients around the human body. 
However, it can also carry pathogens, especially in the blood of an infected person. The most 
common example is the presence of HIV in the blood due to blood-to-body fluid contact with 
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an infected person or syringe. Contaminating pathogens in blood cover a huge range, 
depending on the history of the donor and the degree of care taken in the handling of the 
donation in the processing stage.  
 
Inactivation of viruses in blood can be complicated because blood is a heterogeneous mix of 
various components. Intracellular pathogens which reside in blood cells are especially 
protected against physical methods such as filtration or washing. Detergent has been 
successfully used for virus inactivation in plasma but they are unsuitable for platelets and 
erythrocytes as they can damage the cellular membranes [44]. 
 
The use of PDT in blood disinfection can reduce collateral damage. Three procedures are 
used clinically or approved for clinical trials: methylene blue (with visible light) [45], 
amotosalen HCl (with UV light) [46] and riboflavin (with UV light) [47]. Of these three, the 
methylene blue-mediated is a more established means of blood product disinfection. The 
amotosalen HCl and riboflavin procedures employing UV light potentially lead to host 
damage due to high mutation frequency. In the methylene blue procedure, the plasma is 
filtered through a membrane to eliminate cellular contamination The plasma is subsequently 
mixed with  methylene blue hydrochloride and illuminated at 590nm for 20 minutes. Residual 
methylene blue and its photo-products are later removed through filtration. [48]. Although 
this method is effective in significantly reducing viral count, it also decreases fibrinogen 
activity, which is important for blood coagulation. Due to such safety concerns, extensive 
studies have been done to determine the safety of PDT in its clinical applications such as 




2.3 Factors that affect the efficacy of current PDT technique  
 
2.3.1 Photosensitizer hydrophobicity 
 
Photosensitizer hydrophobicity is important in determining antiviral activity. Majority of 
photosensitizers are highly hydrophobic and normally aggregate in aqueous solutions, 
affecting their photochemical and photobiological properties. In addition, first generation 
photosensitizers possess limitations such as low specificity and high collateral damage. 
Considerable efforts have been made to overcome this by means of drug delivery system [50].  
 
2.3.2 Light source 
 
Current light sources which are in the UV or visible light region have limited tissue 
penetration ability which restricted the amount of light to be delivered to the target sites and 
thus reduced PDT efficacy in treating localized infected tissues. In addition, cell pigmentation 
usually absorbs strongly in the visible light region which overlaps well with the absorption 
spectra of most photosensitizers and better light sources are needed in order to avoid 











2.4 Upconversion nanoparticles (UCNs) 
 
2.4.1 Upconversion mechanism 
 
The exact mechanisms involved in upconversion are varied and complex and can be found to 
operate in isolation or in combination [51]. Upconversion is a non-linear optical process 
involving multiple stages of absorption and fluorescence which results in generation of 
shorter wavelengths. Excitation and emission entities (usually ions) are involved in producing 
upconversion phenomenon (Figure 2.3). When excited with energy of suitable wavelength, 
both excitation and emission entities achieve a higher excitation state. However, instead of 
radiative dissipation, the excitation entity non-radiatively transmits the excess energy to 
emission entity, thereby pushing it to a still higher excited state. The emission entity 
subsequently returns to the ground state and excess energy is emitted as short wavelengths of 
high energy. 
 
Figure 2.3 Mechanism of upconversion process. (Reproduced with permission from Elsevier 





2.4.2 UCN core materials and dopants 
 
The basic structure of UCNs consists of transition metal (3d, 4d, 5d), lanthanide (4f), or 
actinide (5f) dopant ions embedded in the lattice of an inorganic crystalline host. Of these 









) have multiple metastable states, making them well-suited for UC. 
Although a single lanthanide ion is sufficient to produce the upconversion effect, co-doping is 
usually favored as most lanthanide ions have low absorption cross-sections leading to weak 
emission. To enhance upconversion efficiency, co-doping between two different lanthanide 
ions, the first serving as absorber and other acts as emitter, is generally done. Ytterbium 
(Yb
3+
) ion, which possesses larger absorption cross-section in the NIR region, is often used as 




) and holmium (Ho
3+
) ions, on the other hand, 
are frequently used emitter ions due to their equally spaced energy levels that facilitate 
photon absorption and energy transfer in upconversion processes [52].  
 
Another important component of UCNs is the host materials, which determines the optical 
properties and emission efficiency. The desired host materials should have close lattice 
matches with the dopant ions and low lattice phonon energies to minimize energy losses and 
maximize radiative emissions. Halide-based compounds are mostly used due to their low 
phonon energies but the hygroscopic nature of the heavier halides makes the fluorides a more 
popular choice [52].  To date, many host materials as well as lanthanide dopant ions have 
been utilized to synthesize UCNs with different emissions by varying host-dopant 









 nanoparticles have been reported as the materials which produce superior 




2.4.3 UCN-based PDT 
 
UCNs with its unique optical properties, provide a possible solution to all the limitations 
faced by the current PDT technique. First of all, the ability of these nanoparticles to convert 
NIR radiation to visible light can expand the use of PDT due to the greater light penetration 
of NIR in biological tissues [54]. Moreover, cells and tissues absorb weakly in the optical 
window of the NIR region. Thus, the use of NIR light resolves the issue of weakening light 
delivery due to absorption of light by cell pigmentations or hemoglobin in blood. Although 
not many literatures can be found on the use of UCNs for PDT, the development of UCN-
based PDT as a novel treatment modality has attracted considerable interests recently. 
Current works on UCN-based PDT are focusing on its use for cancer treatment and 
can be classified into polymer-based and silica-based approaches. 
 
In the polymer-based approach, PEI and PEG have been used to provide capping layers in 
which photosensitizers get ensconced. Our group [55] attached zinc phthalocyanine (ZnPC) 
photosensitizers to the surface of PEI-coated UCNs by physical adsorption. Folic acid was 
further conjugated for specific targeting to the colon cancer cells. Results showed reduced 
cell viability upon NIR irradiation. Ungun et al. [56] has synthesized three-layer 




 UCNs as the core, porphyrin photosensitizers 
as the middle layer and a PEG polymer coat as the outer layer. They have demonstrated high 
photosensitizer-to-UCN ratio of 1:3 but the PDT efficacy of these UCNs has not been proven.  
The other design utilizes silica as a protective layer in which the photosensitizers are 
impregnated. Using such a strategy, Zhang et al. [57] doped merocyanine-540 
photosensitizers into silica-coated UCNs which were further functionalized with breast 
cancer-targeting antibodies. Based on the optical and fluorescence images obtained, UCN-
treated cancer cells were dead or gradually dying after NIR irradiation. In this case, the 
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release of ROS is hampered by the non-porous silica, therefore resulting in low PDT efficacy. 
By using mesoporous-silica-coated UCNs, release of ROS and oxygen diffusion will not be 
hampered. Our group [58] reported such mesoporous UCNs in which the particles were first 
coated with a thin layer of silica followed by subsequent coating of mesoporous silica layer 
which was loaded with ZnPc. Cell viability of the treated bladder cancer cells was 
significantly lower compared to the controls. Additionally, production of singlet oxygen from 
these ZnPc-loaded nanoparticles in live cells has been proven [59].  
 
Although UCN-based PDT has been shown to be a potential therapeutic option against cancer 
cells, no attempt is made to explore the possibility of inactivating viruses via this UCN-based 




Chapter 3: PEI-coated UCNs for photodynamic 
inactivation of viruses  
3.1 Introduction 
 
Although photodynamic inactivation of viruses via PDT has been reported, acceptance of this 
therapy is considerably low due to several shortcomings such as light sources with limited 
tissue penetration ability, hydrophobic photosensitizers and skin photosensitivity for 
prolonged periods. Nanoparticles, in this case, upconversion nanoparticles (UCNs), are used 
in the development of ‘nano-transducers’ that could potentially address the shortcomings of 
the current PDT set-up.  
 
In our group, we have synthesized UCNs that consist of NaYF4 nanocrystals co-doped with 




 surrounded by a layer of PEI. ZnPc, the photosensitizer, is 
physically adsorbed to the surface of PEI-coated UCNs [60] (Figure 3.1).   
 




 ions are excited to metastable excited 
state. Yb
3+
 ion, which normally acts as absorber ion due to its large absorption cross-section 





 ion then attains higher excited state and correspondingly emitting a high energy 




 UCNs convert 
NIR light to visible light with two distinct peaks at 510-570 nm (green) and 640-680 nm (red) 
regions. ZnPc absorbs the fluorescence emitted by the doped ions and becomes excited to a 
triplet state. This triplet state is not long-lived and when it returns to the original ground-state, 
the energy released by ZnPc diffuses to the surrounding. Nearby molecular oxygen are 
converted to singlet oxygen species, which would result in viral inactivation through genome 
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(DNA or RNA) destruction, probably through oxidative degradation of guanine residues or 
structural degradation of the virus itself (as discussed in Section 2.1.1).    
 
 
The PEI-coated UCNs were synthesized with established protocol (one-pot synthesis using a 
hydrothermal method) and well-characterized by our group members [60]. As mentioned in 
Section 2.4.2, NaYF4 was chosen as the host material due to its superior upconversion 















                                                  Legend:           Yb
3+
          Er
3+
            ZnPc 
Figure 3.1 Schematic drawing of structure and mechanism of action of the PEI-coated ZnPc-
attached UCN.  
 
PEI is a hydrophilic polymer consisting of a number of amino groups. The advantages of 





core in aqueous solutions and confers functional groups for bioconjugation. Both low 
molecular weight and high molecular weight PEI have been used to synthesize the 





NaYF4 host matrix 




with the use of high molecular weight PEI as it contains more coordination sites which 
facilitate enhanced binding of PEI to the UCN surface and reduce nanoparticles aggregation 
efficiently. 
 
The synthesized particles are 50 nm in diameter (by average), spherical and monodispersed. 
High crystallinity of the nanoparticles was observed with hexagonal phase as the dominant 
phase and a secondary cubic phase. Upon excitation by 980 nm NIR light, the nanoparticles 
emit visible lights with dual peaks in the green and red regions at 540 nm and 655 nm 
respectively in aqueous solutions. The combination of these two peaks yielded the resultant 
visible emission which appears greenish-yellow.  
 
ZnPc is bound to the surface of the nanoparticles via physical adsorption. Phthalocyanine is a 
non-polar macrocyclic compound which bears structural similarity to porphyrin, except at the 
tetrapyrrolic rings. The presence of the central metal ion, in this case zinc ion, stabilizes the 
structure and gives high yield of singlet oxygen (Figure 3.2). ZnPc was chosen because it is 
the second generation photosensitzer with desired properties such as high absorption 




/cm), effective singlet oxygen generator and rapid removal from the 
body [61, 62]. Moreover, the excitation of ZnPc falls within the red region with excitation 
maximum at 674 nm which overlaps considerably with the red emission of the PEI-coated 
UCNs in the range of 650-675 nm. The overlapping allows ZnPc, in close contact with the 
nanoparticles, to absorb the visible emissions released by the nanoparticles after being 















Figure 3.2 Chemical structure of ZnPc photosensitizer (from Sigma-Aldrich’s website; 
http://www.sigmaaldrich.com/catalog/product/aldrich/341169?lang=en&region=SG)  
 
These PEI-coated UCNs have been well-characterized and used in our group for PDT in 
cancer cells [55]. In this chapter, the feasibility of the UCN-based photodynamic inactivation 















Polyethylenimine (PEI, branched polymer (-NHCH2CH2-)x(-N(CH2CH2NH2)CH2CH2-)y) of 
molecular weight 25kD, sodium chloride (NaCl, ≥ 99.0%), yttrium chloride hexahydrate 
(YCl3•6H2O, 99.99%), ytterbium oxide (Yb2O3, 99.99%), erbium oxide (Er2O3, 99.99+%), 
ammonium fluoride (NH4F, 98+%), zinc phthalocyanine (ZnPc, 97%), Roswell Park 
Memorial Institute-1640 (RPMI-1640) medium, L-15 medium (Leibovitz), crystal violet, 
methanol, bovine serum albumin (BSA) were purchased from Sigma-Aldrich, USA. Fetal 
bovine serum (FBS) and penicillin-streptomycin were purchased from PAA Laboratories 
GmbH, Austria. Trypsin-EDTA and (0.5% Trypsin with EDTA•4Na) was purchased from 
GIBCO Invitrogen, USA. Phosphate-buffered saline (PBS) was purchased from 1st Base, 
Singapore. Sodium bicarbonate and formaldehyde (37%) were purchased from Merck KGaA, 
Germany. Carboxymethylcellulose (CMC) sodium salt (Aquacide II) was purchased from 
EMD Chemicals, USA. VD-IIIA diode pumped solid-state (DPSS) NIR Laser Driver was 
purchased from PhotoniTech, Singapore.  
 






 nanoparticles were synthesized using a hydrothermal synthetic 
procedure developed in our laboratory [60]. 10 mL NaCl, 8 mL YCl3, 1.8 mL YbCl3, 0.2 mL 
ErCl3 and 20mL PEI (25 kDa) were added to 60 mL ethanol. A suitable amount of NH4F was 
later added after gentle stirring. The solution was then transferred to a Teflon-lined autoclave 
flask and heated at 200 
o
C for 24 h with continuous stirring. Nanoparticles were collected by 
centrifugation followed by a few times of washing with ethanol and DI water. Subsequently, 
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the nanoparticles were vacuum-dried and kept in DI water at room temperature. ZnPc was 
attached to the nanoparticles’ surface via physical adsorption by adding the same volumes of 
ZnPc (500 nM) and nanoparticles (4.4 mg/mL) in ethanol before shaking gently for 30 
minutes in room temperature. The mixture was centrifuged at 10000 rpm for 10 min, 
supernatant was cautiously withdrawn and the particles were resuspended in PBS. The 
nanoparticles were washed twice to remove unbound ZnPc.  
 
3.2.3 Cell culture 
 
Two cell lines were cultured and used for different experiments. The cell lines were BHK-21 
(baby hamster kidney cells) and C6/36 (Aedes albopictus mosquito cells). BHK-21 cells were 
cultured in RPMI-1640 medium while C6/36 cells were cultured in L15 medium. All the cell 
culture media were supplied with FBS and penicillin-streptomycin as antibiotics. For L15 
medium, FBS was heat inactivated at 56 
o
C for 30 min before being added into the medium. 
Cell culture media that were supplemented with 10% FBS were used as growth media for the 
cell lines while cell culture media with 2% FBS were used as maintenance media to enable 
cell survival. The pH of RPMI-1640 was adjusted to the range of 7.2 – 7.4 with sodium 
bicarbonate. All the cells, except C6/36 cells, were cultured in 75 cm
2
 flasks and incubated in 
a humidified incubator with 5 % CO2 at 37 
o
C. C6/36 cells were incubated in dry incubator 




Cells were sub-cultured from confluent monolayer. The cell culture medium was first 
discarded and the cell monolayer was washed with 5 mL of PBS. 2 mL of trypsin was then 
added and the flask was placed in an incubator for 3-5 min at 37 
o
C to detach the cells from 
the flask. 8 mL of cell culture medium was added to the cell suspension to neutralize the 
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enzymatic activity of trypsin. Multiple pipetting of the cell culture medium resulted in a 
single cell suspension. An appropriate amount of cells was re-seeded in the flask and the rest 
of the cells were discarded. The flask was then incubated in an incubator at an appropriate 
temperature. Cell monolayer that reaches confluency in 3 to 4 days was used for experiments.  
 
To seed a certain amount of cells for experiments, cell counting using hemocytometer was 
used. The hemocytometer and glass coverslip were first cleaned with 70% ethanol. The 
coverslip was placed over the hemocytometer surface at a height of 0.1 mm so that the total 
volume for each of the nine 1 mm
2
 squares of the counting grid is 0.1 mm
3
. After 
trypsinization, one drop of cell suspension was introduced into one of the V-shaped wells 
with a micropipetter and the area under the coverslip was filled by cell suspension due to 
capillary action. The hemocytometer was then placed on a microscope stage and the counting 
grid was observed under 10X objective using a brightfield microscope. The cells in the four 
corner squares were counted. Only the cells on the top and left-hand sides of each square 
were included to avoid bias. The average number of cells in each square was used to calculate 
the cell concentration: 












3.2.4 Infection of cells 
 
3.2.4.1 Viruses used  
The virus used was Dengue virus serotype 2 (DENV2, New Guinea C strain) which was 
propagated on C6/36 cells. Viruses were harvested at the appropriate timing post-infection 
(p.i.) from the virus-infected cells. 
 
3.2.4.2 Preparation of virus stock   
 
The cell culture medium was discarded and the cell monolayer was rinsed with 5 mL of PBS. 
Multiplicity of Infection (M.O.I.) of 10 was used. 1 mL of virus suspension was used for the 
infection of cell monolayer in a 75cm
2
 flask. The flask was incubated at 37 
o
C for 1 hour and 
rocked every 15 minutes to ensure even infection of the whole flask. After 1 hour, 14 mL of 
maintenance medium (cell culture medium with 2 % FBS) was added to the flask. The cells 
were incubated at 28 
o
C until the cytopathic effects of the respective cell lines became 
pronounced. DENV2 was harvested after four days of incubation, when syncytial formation 
on C6/36 cells was completed. To harvest the viruses, the extracellular virus-containing 
supernatants were collected and spun at 1500 rpm for 10 minutes to remove cellular debris. 
The virus supernatants were then aliquoted into sterile cryovials, sealed and immediately 
stored at -80 
o










3.2.4.3 Plaque Assay 
 
The amount of viruses harvested was determined and the virus titer, which is the 
concentration of infectious viral particles, was calculated. Ten-fold serial dilutions of the 
DENV2 samples up to the dilution factor of 10
-6 
were prepared in maintenance media of 
RPMI 2 % FBS. Aliquots of 100 μL from the appropriate dilutions were inoculated in 
triplicates onto monolayers of confluent BHK-21 cells grown in sterile 24-well tissue culture 
plate (plated at 62,500 cells/well). The virus-inoculated monolayers were incubated for an 
hour at 37 
o
C with rocking every 15 min to ensure even distribution of virus inocula. After 1 
h of incubation, the inocula were removed upon washing thrice with PBS. 1 mL of semi-solid 
medium, 2 % carboxymethylcellulose (CMC) in cell culture medium containing 2 % FBS, 
was then layered onto the virus-infected cell monolayers. The plates were incubated at 37 
o
C 
in a humidified incubator with 5 % carbon dioxide for five days. After incubation, circular 
zones of infected cells called plaques were formed. Plaques were visualized by staining the 
cell monolayer with 0.5 % crystal violet solution overnight at room temperature. Plaques 
were counted and only wells in the range of between 10 and 100 plaques were accounted for 
in order to minimize error. Number of plaques counted, in combination with the dilution 
factor from which the plaques were counted were used to calculate the virus titer, expressed 
as plaque-forming units per millilitre (PFU/mL). PFU values indicate the number of 
infectious virus particles for a particular sample with an assumption that a single plaque 








3.2.5 Photodynamic inactivation of viruses in suspension 
 
We first performed an experiment to examine the feasibility of this novel strategy by 
irradiating 100 µl of DENV2 (6.36 log10 PFU/mL) in L15 medium each containing 0.5 
mg/mL ZnPc-attached PEI-coated UCNs (ZnPc-PEI-UCNs), 0.5 mg/mL PEI-UCNs (without 
ZnPc) and 0.1 mM ZnPc . A control sample containing only DENV2 suspension was also 
incorporated for this study. All these samples were exposed to NIR irradiation (980 nm) at 
the fluences of 20 and 40 kJ/cm
2
 (laser power of 0.47 W and irradiation time of 14 min 11 s 
and 28 min 22 s respectively). Additionally, a similar set of samples which act as dark 
controls were prepared in parallel and kept in the dark without NIR irradiation for the same 
period of time as the irradiation time of the samples exposed to NIR light. All the viral 
samples were then collected and virus titers of DENV2 were determined by plaque assay 
using BHK-21 cell line based on the method mentioned in Section 3.2.4.3. Reduction in virus 
titers was obtained by subtracting the virus titers of the NIR light-treated samples from the 
virus titers of their associated dark controls. Photodynamic inactivation efficacy was assessed 
based on percentage reduction of virus titer. Percentage reduction of virus titer was calculated 





The percentage reduction of virus titer tells us the reduction of infectious virus particles due 
to photodynamic treatment. Hence, greater photodynamic inactivation efficacy is achieved 




of virus titer (%) 
Virus titer of 
dark control 
sample (Light -) 
Virus titer of dark control sample 
(Light -) 
Virus titer of 
light-treated 
sample (Light +) 
_ 
x 100 % = 
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Fluence which describes the energy delivered per unit area, is a term normally used for light 
dosimetry with J/cm
2
 as its unit: 
 
           Fluence (J/cm
2
) =  
 
Since the same light source was used throughout the project, laser beam area remained 
constant. According to the vendor of NIR laser driver (PhotoniTech, Singapore), the laser 
beam was in square shape with 0.2 cm in length and 0.1 cm in width. Thus, the laser beam 
area was calculated as 0.02 cm
2




In another study to investigate the effect of nanoparticle concentration on the photodynamic 
inactivation efficacy, 100 μL of DENV2 (6.36 log10 PFU/mL) in L15 medium (DENV2 virus 
suspension) were mixed with a range of ZnPc-PEI-UCN concentrations (0, 2, 4.4, 44, 440, 
4400 µg/mL) in 96-well tissue culture plate under aseptic conditions. These samples were 
irradiated with NIR light at 980 nm using VD-IIIA DPSS NIR Laser Driver at the fluence of 
14 kJ/cm
2
 (0.47 W and irradiation time of 10 min) with the distance between the light source 
and the viral samples at 5 cm. A similar set of samples were also prepared and they were kept 
in the dark for the same duration as the NIR irradiation time of the light-treated samples. The 
treated samples were then stored in cryovials at -80 
o
C and virus titers were determined via 
plaque assay as described in Sections 3.2.4.3. All experiments were performed in triplicate. 
Reduction in virus titers was obtained by subtracting the virus titers of the NIR light-treated 
samples from the virus titers of their associated dark controls. Photodynamic inactivation 
efficacy was assessed based on percentage reduction of virus titer as described in the 
feasibility study above. 
  
  Light source power (W) x Irradiation time (s) 
 







3.3 Results and Discussion 
 
3.3.1 Physical properties of PEI-coated NaYF4:Yb3+/Er3+ nanoparticles 
 
In order to investigate the feasibility of UCN-based photodynamic inactivation system as a 




 nanoparticles was first 
employed as the pilot model for this purpose. Transmission electron microscopy (TEM) 
images showed that the nanoparticles were spherical with a mean particle size of 50 nm in 
diameter [60].  
 
Upon exposure to NIR irradiation at 980 nm, the nanoparticles exhibit fairly strong 
upconversion fluorescence by producing green and red emissions with peaks at 540 and 655 
nm respectively. Characterization studies demonstrated that the UCN emissions remain stable 
in various conditions and are biocompatible in vitro. The fluorescence spectrum of the 
nanoparticles and the findings of various characterization studies including the determination 
of singlet oxygen production via disodium 9,10-anthracenedipropionic acid (ADPA) assay 
and cell viability via MTT assay as well as their usage for PDT in cancer cells have been 










3.3.2 Feasibility of UCN-based system for photodynamic inactivation of 
viruses 
 
As this UCN-based system has not been studied elsewhere, photodynamic inactivation of 
DENV2 in suspension was first carried out to explore the effectiveness of these nanoparticles.  
 
Based on the results obtained, the virus titers reduced significantly (P < 0.05) when DENV2 
virus suspension was mixed with 0.5 mg/mL ZnPc-PEI-UCNs and irradiated at both the 
fluences of 20 and 40 kJ/cm
2
 (Figure 3.3 – Figure 3.6). When DENV2 virus suspensions was 
irradiated at the fluence of 20 and 40 kJ/cm
2
 in the presence of 0.5 mg/mL ZnPc-UCNs, the 
virus titers were reduced from 7.26 log10 PFU/mL to 3.49 log10 PFU/mL (a 3.77 log10 
PFU/mL or 52 % reduction) and from 7.16 log10 PFU/mL to 2.94 log10 PFU/mL (a 4.22 log10 
PFU/mL or 58 % reduction) in infectious virus titer respectively. This suggested that more 
than 50 % of the viruses were photodynamically inactivated by ZnPc-UCNs. Meanwhile, a 
minor reduction of infectious virus titers as compared to their respective dark controls were 
observed for the DENV2 virus suspensions added with 0.5 mg/mL PEI-UCNs and 0.1 mM 
ZnPc and irradiated at both the fluences of 20 and 40 kJ/cm
2
. Although capable of producing 
visible emissions for photosensitizer excitation, the PEI-UCNs do not carry ZnPc 
photosensitizers necessary to effect photodynamic inactivation. On the other hand, 
photodynamic inactivation effect was also not seen on virus suspension mixed with ZnPc as 




Figure 3.3 Infectious virus titers of DENV2 irradiated at the fluence of 20 kJ/cm
2
 in the 
presence of 0.1 mM ZnPc photosensitizers, 0.5 mg/mL PEI-UCNs and 0.5 mg/mL ZnPc-PEI-
UCNs. All experiments were performed in triplicate and error bars represent standard 
deviations of the mean. Statistical analysis was done by comparing light-treated samples to 
their respective dark controls using Student’s t-test, * P < 0.05.  
 
Figure 3.4 Percentage reduction of virus titer for DENV2 irradiated at the fluence of 20 
kJ/cm
2
 in the presence of 0.1 mM ZnPc photosensitizers, 0.5 mg/mL PEI-UCNs and 0.5 
mg/mL ZnPc-PEI-UCNs. Error bars represent standard deviations of the mean. Statistical 
analysis was done by comparing the samples to the control (the DENV2-only sample) using 


























































































Figure 3.5 Infectious virus titers of DENV2 irradiated at the fluence of 40 kJ/cm
2
 in the 
presence of 0.1 mM ZnPc photosensitizers, 0.5 mg/mL PEI-UCNs and 0.5 mg/mL ZnPc-PEI-
UCNs. All experiments were performed in triplicate and error bars represent standard 
deviations of the mean. Statistical analysis was done by comparing light-treated samples to 
their respective dark controls using Student’s t-test, * P < 0.05.  
  
 
Figure 3.6 Percentage reduction of virus titer for DENV2 irradiated at the fluence of 40 
kJ/cm
2
 in the presence of 0.1 mM ZnPc photosensitizers, 0.5 mg/mL PEI-UCNs and 0.5 
mg/mL ZnPc-PEI-UCNs. Error bars represent standard deviations of the mean. Statistical 
analysis was done by comparing the samples to the control (the DENV2-only sample) using 





























































































Although photodynamic inactivation effect was not seen on virus suspension samples with 
PEI-UCNs and ZnPc photosensitizers, a slight reduction in virus titers was observed on 
samples irradiated at the fluence of 20 kJ/cm
2
 and the reduction increased with fluence of 40 
kJ/cm
2
. This was due to the light photodamage effect of the NIR irradiation. As evidenced 
from the sample with DENV2 only virus suspension, the virus titer reduction was only 0.22 
log10 PFU/mL when irradiated at the fluence of 20 kJ/cm
2
 but further increased to around 1 
log10 PFU/mL when the fluence was raised to 40 kJ/cm
2
. The percentage reduction of virus 
titer showed a 10% increase from 3% (at 20 kJ/cm
2
) to 13% (at 40 kJ/cm
2
) for samples with 
DENV2 only virus suspension. The light photodamage effect was to be expected due to the 
heat generates from the NIR irradiation. However, it can be deduced from the results that, up 
to the fluence of 40 kJ/cm
2
, the photodamage to DENV2 viruses is negligible as the reduction 
in virus titers was statistically insignificant. 
 
Overall, this study has demonstrated that PEI-coated UCNs with attached ZnPc 
photosensitizers is able to photodynamically inactivate viruses and the development of UCN-
based photodynamic inactivation system is feasible.   
 
3.3.3 Photodynamic inactivation of DENV2 in suspension 
 
After demonstrating that ZnPc-UCNs were feasible to inactivate viruses, we further explored 
the UCN-based photodynamic inactivation of viruses in suspension by examining the effect 
of nanoparticle concentration on photodynamic inactivation efficacy. The ZnPc-PEI-UCNs at 
various concentrations were mixed with DENV2 and exposed to 980 nm NIR light at the 
fluence of 14 kJ/cm
2
 (as described in Section 3.2.5).  
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The results showed that there was a concentration-dependent reduction in the infectious 
DENV2 titers. The infectious titers of DENV2 samples that were irradiated in the presence of 
the nanoparticles were compared against their respective dark controls, which were samples 
without NIR irradiation. For all the experimental conditions, photodynamic inactivation 
efficacy was the least effective using the lowest nanoparticle concentration of 2 µg/mL. 
Significant reduction in virus titers was observed for nanoparticle concentrations of 4.4, 44 
and 440 µg/mL. Compared to their respective dark control samples, virus titers reduced 3.78 
log10 PFU/mL (62 % reduction), 4.06 log10 PFU/mL (66 % reduction) and 5.00 log10 PFU/mL 
(82 % reduction) respectively for these three concentrations (Figures 3.7 and 3.8). However, 
gradual reduction was observed when nanoparticle concentrations were increased 10-fold 
from 4.4 µg/mL to 44 µg/mL and finally to 440 µg/mL for the light-treated samples. Virus 
titer of the light-treated sample of 44 µg/mL was recorded at 2.3 log10 PFU/mL and 1.1 log10 
PFU/mL for 440 µg/mL. Although there was an increase of 100-fold in concentration, virus 
titer reduction of only 1.2 log10 PFU/mL was observed. This could be due to the dislodgment 
of ZnPc from the surface of the nanoparticles. As ZnPc photosensitizers were only adsorbed 
physically to the surface of the PEI-UCNs, frictions between the nanoparticles and the 
interaction of PEI-UCNs with the microenvironment of cell culture medium could result in 
ZnPc being detached from the nanoparticles easily, thus lowering the photodynamic 





Figure 3.7 Infectious virus titers of DENV2 mixed with different ZnPc-PEI-UCN 
concentrations and exposed to 980 nm NIR light at the fluence of 14 kJ/cm
2
. All experiments 
were performed in triplicate and error bars represent standard deviations of the mean. 
Statistical analysis was done by comparing light-treated samples to their respective dark 
controls using Student’s t-test, * P < 0.05.  
 
 
Figure 3.8 Percentage reduction of virus titer for DENV2 irradiated with different ZnPc-PEI-
UCN concentrations at the fluence of 14 kJ/cm2. Error bars represent standard deviations of 
the mean. Statistical analysis was done by comparing each of the samples to the 0 µg/mL 




















































































* * * 
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On the other hand, DENV2 viruses were completely inactivated at 2200 µg/mL, the highest 
concentration of ZnPc-UCNs used in this study. The complete inactivation was seen for both 
NIR-irradiated and dark control samples. The dark controls, which were samples without NIR 
irradiation, not only acted as controls for the light-treated samples but also served to assess 
the nanoparticle toxicity on viruses. The results showed that ZnPc-PEI-UCNs were not toxic 
to viruses for all the concentrations tested except 2200 µg/mL. The virus titers for dark 
control samples of 2, 4.4, 44 and 440 µg/mL were ranged from 6.06 log10 PFU/mL to 6.16 
log10 PFU/mL which did not deviate much from the original virus titer used for this 
experiment (6.37 log10 PFU/mL). Thus the complete inactivation of viruses as seen for the 
NIR-irradiated sample at the concentration  of 2200 µg/mL was not due to photodynamic 
action but rather because the nanoparticles were too toxic to the viruses at this concentration 





In conclusion, the findings from this work demonstrate the feasibility of UCN-based PDT to 
photodynamically inactivate viruses with advantages over current PDT technique. In order to 
overcome the problem of ZnPc dislodgment, the current design of ZnPc-PEI-UCN should be 




Chapter 4: Synthesis and characterizations of 
mesoporous silica-coated UCNs 
4.1 Introduction 
 





 UCNs as shown in the previous chapter. By attaching ZnPc 
photosensitizer to the PEI-coated UCNs via physical adsorption, significant reduction of virus 
titer due to photodynamic inactivation effect was achieved. However, this design suffers 
some setback which might hamper its development for clinical use. As ZnPc photosensitizers 
were attached to the nanoparticles via physical adsorption, these photosensitizers may not be 
firmly attached to the nanoparticles and can easily dislodge in the complex biological 
environment, causing low attachment efficiency. In addition, there is also concern of PEI 
cytotoxicity [63] which could potentially cause collateral damage to host cells by disruptions 
to cell membrane (causing necrosis) and mitochondrial membrane (causing apoptosis) [64]. 
Thus, current design of PEI-coated UCNs needs to be improvised in order to develop a 
clinically-viable and biocompatible UCN-based PDT system.  
 
Apart from PEI polymer which was being used by our group for UCN-based PDT, 
polyethylene glycol (PEG) has also been explored by others. Ungun et al. [56] has 




 UCNs as the core, 
porphyrin photosensitizers as the middle layer and a PEG polymer coat as the outer layer. 
They have demonstrated high photosensitizer-to-UCN ratio of 1:3 but the PDT efficacy of 




In addition to polymer-based approach, another design utilizes silica as a protective layer in 
which the photosensitizers are impregnated. Using such a strategy, Zhang et al. [57] doped 
merocyanine-540 photosensitizers into the silica shell of UCNs which were further 
functionalized with antibodies. However, the release of ROS is hampered by the non-porous 
silica, thereby resulting in low PDT efficacy.  
 
Based on the shortcomings of our current design and the efforts made by other groups, it 
seems imperative to synthesize UCNs which are able to carry hydrophobic photosensitizers in 
complex aqueous biological environment without them being easily dislodged. In addition, 
the generation and production of ROS must not be hampered by the UCN structure. 
Mesoporous silica materials offer advantages such as large surface area and porous structures 
which could act as repositories to store hydrophobic photosensitizers. Moreover, the size of 
the porous structures is tunable, allowing heterogeneous molecules to be kept in the 
mesoporous silica structures [65, 66]. Most importantly, the porous structures that 
encapsulate photosensitizers enable ROS produced from the PDT reactions to be released out 
from the pores with ease. Besides good solubility in water and organic solvents, silica-coating 
has been proven to confer several advantages such as being stable in biological buffers, 
biocompatible and allows easy access for grafting of specific ligands, polymers and 
biomolecules [67-69], all of which are important for biomedical applications.  
 
In view of the advantages of mesoporous silica, this material was selected to replace PEI as 





 coated with two layers of silica, the inner layer of amorphous silica and 
outer layer of mesoporous silica. Subsequently, the ZnPC molecules are loaded into the 
mesoporous silica (Figure 4.1). Our group has reported the successful synthesis of these 
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nanoparticles [58]. It is expected that by loading the photosensitizers into porous silica, the 
release of ROS and oxygen diffusion will not be hampered.  
 
 






















Sodium chloride (NaCl, ≥99.0%), yttrium chloride hexahydrate (YCl3•6H2O, 99.99%), 
ytterbium oxide (Yb2O3, 99.99%), erbium oxide (Er2O3, 99.99+%), ammonium fluoride 
(NH4F, ≥98%), oleic acid (OA, ≥99%), 1-octadecene (ODE, ≥99.5%), Igepal CO-520, 
cyclohexane (≥99%), tetraethyl orthosilicate (TEOS, ≥99.9%), ammonia (NH3, ≥99.9%), 
methanol, sodium hydroxide (NaOH, ≥97%), acetone (≥99.5%),octadecyltrimethoysilane 
(C18TMS ≥90%), ammonia hydroxide (NH4OH, 33%), pyridine (99.8%), dimethyl sulfoxide 
(≥99.9%), zinc (II) phthalocyanine (ZnPc, 97%) and 9,10-anthracenediyl-bis(methylene) 
dimalonic acid (ABDA, ≥90%) were purchased from Sigma-Aldrich, USA. Ethanol (EtOH, 
89 – 91%) was purchased from VWR International LLC. Phosphate-buffered saline (PBS) 
was purchased from 1st Base, Singapore.  
 
4.2.2 Synthesis of mesoporous silica-coated NaYF4:Yb3+/Er3+ nanoparticles 
 
The mesoporous silica-coated nanoparticles were synthesized with established protocol [58]. 






 upconversion nanocrystals: 0.8mmol YCl3, 0.18n mmol YbCl3 
and 0.02 mmol ErCl3 were mixed in a 50 mL round-bottom flask with 6 mL OA and 15 mL 
ODE. In order to form a homogeneous solution, the mixture was heated to 160 
o
C and 
subsequently cooled to room temperature. 2.5 mmol NaOH and 4 mmol NH4F in 10 mL 
methanol was subsequently added and continuously stirred for 30 min. This mixture was 




C for 10 minutes and flow with Argon for 1 h. After the mixture was cooled down, 
upconversion nanocrystals were precipitated with ethanol and washed three times with 
ethanol-water solution. 
 
Silica coating onto the upcvonversion nanocrystals via a microemulsion method: The 
synthesized upconversion nanocrystals (0.01 M in 4 mL cyclohexane) were mixed with 0.1 
mL Igepal CO-520 and 6 mL cyclohexane. The solution was stirred continuously for 10 min 
followed by the addition of 0.4 mL Igepal CO-520 and 0.08 mL ammonia (30 wt %). After 
stirring, the flask was sonicated for 20 min in a sealed manner. 0.04 mL TEOS was 
subsequently added and this flask was shook for 48 h at 600 rpm. After that, acetone was 
used to precipitate silica-coated nanoparticles and further washed with ethanol-water solution 
two times before the silica-coated nanoparticles were kept in DI water.   
 
Additional coating of mesoporous silica onto the nanoparticles: A solution containing 100 
mL TEOS and 40 µL C18TMS in 20 µL of ethanol was prepared in a round-bottom conical 
flask before the silica-coated nanoparticles was added to the solution. 1 mL NH4OH (33%) 
was further added into the solution and continuously stirred for 6 h at room temperature. 
Through centrifugation, the nanoparticles were recollected and washed with ethanol and 
water for 3 times. The nanoparticles were then placed in a furnace and heated at 500 
o
C for 6 
hours in order to form a mesoporous silica layer on the nanoparticles’ surface through the 







4.2.3 Characterizations of the nanoparticles 
 
The size and shape of the mesoporous-silica coated nanoparticles were determined by TEM. 
Nanoparticle solution in a small volume was dropped onto a formvar/carbon-coated grid (300 
mesh) and left dried on the bench at room temperature. Samples were then imaged using 
JEOL 2010 transmission electron microscope with accelerating voltage of 200 kV. The 
surface charge of the nanoparticles was measured using ZetaSizer NanoZS (Malvern 
Instruments, UK). 1 mg/mL mesoporous silica-coated nanoparticles in deionized distilled 
water were filled in a Zeta Cell. This was placed in the ZetaSizer NanoZS chamber and the 
zeta potential measured. The zeta potential for nanoparticles was measured five times with 30 
readings taken for each time. The size distribution of the nanoparticles in solution was 
studied by dynamic light scattering (DLS) using ZetaSizer NanoZS also. The method and 
sample preparation were similar as mentioned above. The surface area and pore size 
distribution of the mesoporous silica-coated nanoparticles were determined by using 
Quantachrome Nova 2000E Surface Area and Pore Size Analyzer (Quantachrome 
Instruments, USA). 50mg of the nanoparticles were weighed and added into a sample cell. 
The sample was vacuum degassed with nitrogen (N2) flow at 300 
o
C for three hours. The 
purpose of doing this is to remove all the moisture from the sample prior to the actual 
analysis. Then, the degassed sample was used for analysis. For surface area, a twenty points 
adsorption and twenty points desorption isotherm was measured while gas adsorption method 
was used to measure pore size. The UCN’s fluorescence emission spectra were measured 
using SpectroPro 2150i spectrophotometer (Roper Scientific Acton Research , USA) 
equipped with 980 nm VA-II DPSS laser (PhotoniTech, Singapore). 1 mg/mL of 
nanoparticles in deionized distilled water was added into a cuvette. The cuvette was then 
placed in the sample holder of spectrophotometer and the sample was excited by 980 nm 
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laser (current set at 1.5 mA). The fluorescence emission was measured from 450 nm to 700 
nm. 
4.2.4. Preparation of ZnPc standard curve  
 
Different ZnPc concentrations (0.4, 0.8, 1.2, 1.6, 2.0, 2.4, 2.8 and 3.25 µg/ml) in pyridine 
were prepared. 500ul of solution from each concentration sample was added into a cuvette 
and placed in the sample holder of UV-2450 UV-Visible spectrophotometer (Shimadzu 
Corporation, Japan). Absorbance at 674 nm for each sample was recorded and these readings 
against ZnPc concentrations were used to plot the standard curve.  
 
4.2.5 Loading of ZnPc photosensitizers into mesoporous silica of the 
nanoparticles  
 
A typical loading process involves soaking a certain amount of nanoparticles for 24 h in a 
pyridine solution containing ZnPc. After soaking, the ZnPc-loaded nanoparticles were 
recollected by centrifugation and washed 2 times before being kept in L15 cell culture 
medium for experiments. To determine the ZnPc loading amount, 1 mg mesoporous silica-
coated nanoparticles were soaked in 1 mL of different concentrations of ZnPc in pyridine 
solution (0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6 mg/mL) for 24 hours. ZnPc-loaded nanoparticles 
were obtained by centrifugation and the supernatants were kept for absorbance measurement 
using UV-2450 UV-Visible spectrophotometer (Shimadzu Corporation, Japan). The 
absorbance readings at 674 nm were taken and the amount of ZnPc loaded for each sample 





4.2.6 Determination of singlet oxygen (1O2) production  
 
Singlet oxygen production was determined by the photobleaching of 9,10-anthracenediyl-
bis(methylene)dimalonic acid (ABDA). The ZnPc-loaded nanoparticles obtained from ZnPc 
loading in different concentrations of ZnPc solution (0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6 
mg/mL) were used for this purpose. 1 mg of ZnPc-UCN from each ZnPc loading 
concentration was mixed with ABDA (10 µM) in DI water. The solution was then exposed to 
980nm NIR laser at the laser power of 0.47 W for 0, 20, 40, 60 and 80 minutes and the 
fluorescence intensity of ABDA at 407 nm was measured using SpectroPro 2150i 
spectrophotometer (Roper Scientific Acton Research, USA). A control sample of 1 mg void 
UCNs was also exposed to 980 nm NIR laser with the same exposure time. A graph of 
normalized fluorescence intensity at 407 nm for nanoparticles obtained from different ZnPc 
loading concentrations against various time points was plotted.     
 
4.2.7 Determination of ZnPc release profile   
 
1mg of ZnPc-loaded nanoparticles was soaked in 1ml of DI water, 1X PBS, pyridine, DMEM, 
RPMI-1640 and L-15 media respectively for 24 hours. DMEM, RPMI-1640 and L-15 were 
cell culture media supplemented with 10% fetal bovine serum (FBS). After 24 hours soaking, 
the nanoparticles were recollected by centrifugation and the supernatants kept for absorbance 
measurement. UV-Visible absorption spectra of the supernatants were measured using UV-






4.3 Results and Discussion 
 
4.3.1 Physical characterizations of mesoporous silica-coated 
NAYF4:Yb3+/Er3+ nanoparticles 
 
4.3.1.1 Size and shape determinations 
 
TEM can be used for direct determination of size and shape of nanoparticles. Figure 4.2 
shows the mesoporous silica layer with thickness of around 11 nm was successfully coated 
onto the nanoparticles. As revealed by TEM, the porous structures of the mesoporous silica 





 nanoparticles are spherical in shape and have an average size of 70 
nm in diameter. 
  
 




 UCNs. (b) The 







4.3.1.2 Quantification of surface charge  
 
The surface charge of a particle in solution is determined by measuring zeta potential. The 
zeta potential is an illustration of the mean surface charge of the nanoparticles. Surface 
charge is an important factor in solubility of the nanoparticles in polar solutions. The zeta 




 nanoparticles was measured 5 times 
with an average value of -20.4 mV (Table 4.1). As the nanoparticles’ surface was coated with 
mesoporous silica, the value obtained was consistent and in accordance with the fact that 
silica has negative surface charge. 













4.3.1.3 Size distribution and presence of aggregates 
 
The distribution of nanoparticle sizes determined using DLS provides a valuable indicator of 
the presence of aggregates in solution. Aggregates of nanoparticles are several times the size 
of individual nanoparticles and show up as a separate peak in the size distribution graph. The 
synthesized nanoparticles demonstrated a unimodal size distribution of the nanoparticles with 
a single peak, (Figure 4.3). It has an average diameter of 127 nm with polydispersity index 
(PDI) of 0.171. This PDI value corresponds to the monodispersity of nanoparticles in solution 
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as PDI near 0.1 means that the nanoparticles are monidisperse with narrow size distribution 
[70] while PDI in the range of 0.5 – 1.0 shows polydispersity of the sample. It is worth to 
note here that DLS gave an average size of 127 nm in diameter which is bigger than the 
actual size viewed under TEM. The nanoparticle’s size measured using DLS in solution is not 
the true size but includes the hydrodynamic radius of the layers of water molecules that 
attached on the nanoparticle’s surface. This causes a higher value for size measurement. 
 




 nanoparticles in 
DI water. 
 
4.3.1.4 Surface area and pore size distributions 
 
Based on the adsorption/desorption isotherm of N2, the surface area of UCNs was measured 
to be 69.614 m
2
/g. The mesoporous silica-coated UCNs have narrow pore size distribution 
with an average pore size of 3.76 nm in diameter (Figure 4.4). The purpose of degassing the 











4.3.2 Optical characterization of mesoporous silica-coated NAYF4:Yb3+/     
Er3+ nanoparticles 
 





nanoparticles emitted fluorescence in the green and red regions of the visible spectrum with 
two peaks at 545 nm and 658 nm respectively upon excitation with 980 nm NIR laser (Figure 







Figure 4.5 (a) Fluorescence emission spectrum of the mesoporous-silica-coated UCN upon 
excitation at 980 nm.  
 
 
As mentioned, the mesoporous silica-coated nanoparticles, when excited with NIR laser at 
980 nm, emit visible light in green and red regions at 510-570 nm and 640-680 nm 
respectively. Based on the spectra shown in Figure 4.6, there is a good overlap between the 
emission spectrum of UCN and absorption spectrum of ZnPc (which peaks at around 674 nm) 
in the red light region. The overlapping allows ZnPc being encapsulated in the porous silica 
of the nanoparticles to absorb the visible light emitted by the nanoparticles upon excitation by 




Figure 4.6 Emission spectrum of UCN upon excitation by 980 nm NIR laser (blue) and 
absorption spectrum of ZnPc (grey) in the red region of visible light. 
 
4.3.3 Loading of ZnPc photosensitizers into mesoporous silica of the 
nanoparticles 
 
As the generation of ROS and singlet oxygen were mediated by photosensitizers, the amount 
of ZnPc loaded has a direct implication on the photodynamic inactivation efficacy. It is 
expected that higher amount of ZnPc produces better photodynamic inactivation efficacy.  In 
order to optimize the amount of ZnPc photosensitizers loaded into mesoporous silica of the 
nanoparticles, a ZnPc standard curve was first developed based on the UV-Visible 
absorbance readings of standard ZnPc solutions in pyridine (as described in Section 4.2.4). 1 
mg nanoparticles were soaked in 1 mL of different loading concentrations of ZnPc solution 
for 24 hours. After 24 hours, the nanoparticles were recollected by centrifugation and 
supernatants were kept for absorbance readings at 674 nm, which is the absorption maximum 
of ZnPc. The supernatants corresponded to free or unloaded ZnPc photosenstitizers that were 
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not incorporated into mesoporous silica of the nanoparticles. Based on the absorbance 
readings at 674 nm, the amount of ZnPc photosensitizers in the supernatants were calculated 
from the ZnPc standard curve. The amount of ZnPc photosensitizers loaded into the 
mesoporous silica shell could then be obtained from the subtracted value of the amount of 
ZnPc in the supernatant from the initial ZnPc loading amount. As the nanoparticles were 
soaked in 1 mL of ZnPc solution, the initial ZnPc loading amounts used correspond to their 
respective ZnPc loading concentrations. For example, 0.2 mg or 200 µg was the initial 
loading amount for the ZnPc loading concentration of 0.2 mg/mL.     
 
Figure 4.7 Amount of ZnPc photosensitizers loaded into the mesoporous silica-coated 
nanoparticles which were soaked with various ZnPc loading concentrations.  
 
Based on the results obtained (Figure 4.7), it was observed that the amount of ZnPc 
photosensitizers loaded into the mesoporous silica-coated nanoparticles increased with ZnPc 
loading concentration. Higher ZnPc loading concentration will result in more photosensitizers 
being loaded into mesoporous silica of the nanoparticles. 13 µg of ZnPc photosensitizers 
were being loaded into mesoporous silica using the lowest ZnPc concentration of 0.2 mg/mL 
(initial ZnPc loading amount of 0.2 mg) while the highest ZnPc loading concentration of 1.6 




























ZnPc loading concentration (mg/mL) 
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nanoparticles. Loading efficiency was calculated as the percentage of ZnPc loaded amounts 
against their respective initial loading amounts. For the fixed amount of nanoparticles (1 mg) 
soaked in all ZnPc loading concentrations except 0.2 mg/mL, the loading efficiency was 
about the same in the range of 14 – 18 % of their initial loading amounts. The loading 
efficiency for 0.2 mg/mL ZnPc loading concentration (initial loading amount of 0.2 mg) was 
merely 6.52 %. Overall, the optimum loading amount of ZnPc photosensitizers could not be 
determined as the saturation point or plateau was not observed in this study. Higher ZnPc 
loading concentrations could be used to further increase the amount of loaded ZnPc 
photosensitizers until a saturation point or plateau was reached.  
 
4.3.4 Determination of ZnPc loading by singlet oxygen profile via ABDA    
           assay 
 
Although the optimum loading amount of photosensitizers was not determined from the 
previous experiments, studies have suggested that higher amount of photosensitizers do not 
necessary brings better photodynamic effect. There were reports of aggregation-induced 
photosensitizer self-quenching which could lead to reduce photosensitivity and photoactivity. 
This quenching effect is due to aggregation of photosensitizers when high amount of 
photosensitizers is being used. The aggregation causes self-quenching of the fluorescence and 
photoactivity of neighboring photosensitizers, leading to a much reduced ROS generation. 
This quenching phenomenon was also being observed upon the encapsulation of 
photosensitizers into polymeric nanoparticles using two different photosensitizers, porphyrins 
and chlorins [71]. Aggregation-induced quenching was described when silicon 
phthalocyanine (SiPc) was encapsulated into polymeric micelles [72].  ZnPc is also affected 
by self-quenching effect as fluorescence quenching was observed when ZnPc of high 
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concentrations was incorporated into the liposome carrier system [73]. Thus, compare to 
determining the loading amount of ZnPc photosensitizers, it seems more reasonable to 
optimize the ZnPc loading through singlet oxygen profiles of ZnPc-loaded mesoporous silica-
coated nanoparticles (ZnPc-MS-UCNs) which were obtained from ZnPc solutions of different 
loading concentrations. 
 
The production and release of singlet oxygen is the most crucial step in the photodynamic 
action of photosensitizers by converting molecular triplet oxygen to singlet oxygen, thereby 
catalyzing the inactivation of viruses. The production and release of singlet oxygen from the 
mesoporous silica-coated nanoparticles were investigated in this study via the photobleaching 
of 9,10-anthracenediyl-bis(methylene)dimalonic acid (ABDA). 
1
O2 reacts with ABDA and 
produces endoperoxide, thereby causing a decrease in the amount of ABDA. Hence, the 
decrease in ABDA fluorescence intensity is inversely proportionate to the increase in singlet 
oxygen production. The fluorescence intensity of ABDA can be measured at 407 nm, which 
is the emission maximum of ABDA.  
 
As shown in Figure 4.8, the results demonstrated time-dependent decrease of ABDA 
fluorescence intensity, indicating an increase in the production of singlet oxygen over time by 
ZnPc-MS-UCNs. More singlet oxygen was produced as the rate of singlet oxygen production 
was rapid in the first 20 minutes of NIR irradiation. This was evidenced from the ABDA 
fluorescence intensity which reduced notably in the first 20 minutes and stabilized after that. 
The singlet oxygen profiles showed that higher ZnPc loading concentrations did not result in 
better singlet oxygen production efficiency. This is in consistent with the above-mentioned 
aggregation-induced self-quenching effect of photosensitizers. The ABDA fluorescence 
intensity remained unchanged over time for nanoparticles soaked in ZnPc loading 
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concentration of 1.2 mg/mL and was even higher than the control sample of void UCNs 
which showed a very minute reduction in the ABDA fluorescence intensity. Upon 
comparison of all the singlet oxygen profiles, the singlet oxygen profile of nanoparticles 
soaked in ZnPc loading concentration of 0.8 mg/mL showed the highest decrease in ABDA 
fluorescence intensity over time which correlates to the highest amount of singlet oxygen 
being produced. This loading concentration was used for subsequent ZnPc loading in 
preparation of ZnPc-MS-UCNs for photodynamic inactivation experiments. Based on the 
previous study, the ZnPc loading amount of nanoparticles soaked in 0.8 mg/mL ZnPc 
solution was around 130 µg. Thus, this amount was regarded as the optimum ZnPc loading 
amount. 
 
Figure 4.8 Singlet oxygen profiles of ZnPc-MS-UCNs soaked in various ZnPc loading 
concentrations. The production of singlet oxygen was determined via ABDA destruction 
assay. All experiments were performed in triplicate and error bars represent standard 























































After ZnPc photosensitizers have been loaded into mesoporous silica of the nanoparticles, the 
nanoparticles changed from white color to blue-green color, indicating the incorporation of 






   




 nanoparticles (a) 
before (white) and (b) after (blue-green) soaking in ZnPc solution. 
 
4.3.5 ZnPc release profile in aqueous solutions  
 
It is imperative that ZnPc remains intact inside the mesoporous silica of the nanoparticles in 
aqueous biological environment to ensure the continuous singlet oxygen production upon 
exposure to NIR light. Thus, the release profile of ZnPC in various aqueous solutions was 
investigated. As described in Section 4.2.7, the ZnPc-MS-UCNs were soaked in different 
solutions for 24 hours. The nanoparticles were recollected via centrifugation and supernatants 
were kept for absorbance measurements. The supernatants correspond to ZnPc 
photosensitizers that were being leached out from the porous silica of nanoparticles. The 
findings demonstrated that ZnPc molecules were being leached out from the mesoporous 
silica in pyridine but was retained in the porous structure in DI water, PBS and cell culture 
media (Figure 4.10). These findings indicated that ZnPc photosensitizers would remain intact 
in the mesoporous silica after loading and not leaching out when incubated in cell culture 





Figure 4.10 ZnPc release profile of ZnPc-MS-UCNs soaked in pyridine, DI water, 1X PBS 









 nanoparticles. These nanoparticles possess mesoporous silica to store 
photosensitizers. The porous structures of silica ensure that singlet oxygen can be released 
from the pores to the microenvironment with ease. The hydrophobic photosensitizers remain 
intact in the pores when incubated in aqueous solutions. Porous silica protects 
photosensitizers from being degraded in the harsh and complicated biological environment. 
The photosensitizer-loaded nanoparticles are reusable by soaking the particles in pyridine 




Chapter 5: Mesoporous silica-coated UCNs for 
photodynamic inactivation of viruses 
5.1 Introduction 
 




 nanoparticles have been synthesized in our 
group with established protocol [58] and well-characterized with many improved features for 
ZnPc loading as mentioned in the previous chapter. These nanoparticles have been used in 
our group for PDT of bladder cancer cells [58] and the cytotoxic effect via singlet oxygen-
induced apoptosis was demonstrated. Additionally, production of singlet oxygen from these 
ZnPc-MS-UCNs in live cells has been proven [59].  
 
In this chapter, the photodynamic inactivation efficacy of ZnPc-MS-UCNs to inactivate 
DENV2 in suspension was discussed. On the other hand, similar experimental settings were 
carried out in the presence of mouse tissues in order to investigate the ability of NIR light to 
penetrate mouse tissues of a certain thickness to inactivate the viruses in suspension beneath 
the tissues. Current light sources used in clinical settings have limited tissue penetration 
ability which confines their application only to treat superficial lesions and warts. Patients are 
told not to expose their treated area to sunlight so as to avoid further excitation of 
photosensitizers that could harm the healthy cells of the treated area. One of the advantages 
of employing UCNs in this instance is its unique optical properties to be excited by light of 
longer wavelength and produce higher energy emissions with shorter wavelength. Generally, 
longer wavelengths have the ability to penetrate deeper into tissue than light with shorter 
wavelengths. Thus, these nanoparticles when diffuse into the tissues could utilize the NIR 
light to inactivate viruses beneath the skin in order to achieve complete virus inactivation 
outcome. The use of NIR light also circumvents the problem of exposure to sunlight or 
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visible light after treatment as the photodynamic actions of these UCNs will only occur upon 
excitation by NIR light.  




Roswell Park Memorial Institute-1640 (RPMI-1640) medium, L-15 medium (Leibovitz), 
crystal violet and methanol were purchased from Sigma-Aldrich, USA. Fetal bovine serum 
(FBS) and penicillin-streptomycin were purchased from PAA Laboratories GmbH, Austria. 
Trypsin-EDTA (0.5% Trypsin with EDTA•4Na) was purchased from GIBCO Invitrogen, 
USA. Phosphate-buffered saline (PBS) was purchased from 1st Base, Singapore. Sodium 
bicarbonate (NaHCO3) and formaldehyde (37%) were purchased from Merck KGaA, 
Germany. Carboxymethylcellulose (CMC) sodium salt (Aquacide II) was purchased from 
EMD Chemicals, USA. All of the reagents were used as received without further purification. 
Mouse skin tissues of female C57BL/6 mice, 4 – 6 weeks old were obtained from Ms. 
Niagara Muhammad Idris with approval from the NUS Institutional Animal Care and Use 
Committee (IACUC).  
5.2.2 Cell culture 
 
BHK-21 and C6/36 cell lines were cultured and used for different experiments. BHK-21 cells 
were cultured in RPMI-1640 medium while C6/36 cells were cultured in L15 medium. All 
the cell culture media were supplied with FBS and penicillin-streptomycin as antibiotics. For 
L15 medium, FBS was heat inactivated at 56 
o
C for 30 min before being added into the 
medium. Cell culture media that were supplemented with 10% FBS were used as growth 
media for the cell lines while cell culture media with 2% FBS were used as maintenance 
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media to enable cell survival. The pH of RPMI-1640 media were adjusted to the range of 7.2 
– 7.4 with sodium bicarbonate. All the cells, except C6/36 cells, were cultured in 75 cm2 
flasks and incubated in a humidified incubator with 5% CO2 at 37 
o
C. C6/36 cells were 




Cells were sub-cultured from confluent monolayer. The cell culture medium was first 
discarded and the cell monolayer was washed with 5 mL of PBS. 2 mL of trypsin was then 
added and the flask was placed in an incubator for 3 - 5 min at 37 
o
C to detach the cells from 
the flask. 8 mL of cell culture medium was added to the cell suspension to neutralize the 
enzymatic activity of trypsin. Multiple pipetting of the cell culture medium resulted in a 
single cell suspension. An appropriate amount of cells was re-seeded in the flask and the rest 
of the cells were discarded. The flask was then incubated in an incubator at an appropriate 
temperature. Cell monolayer that reaches confluency in 3 to 4 days was used for experiments.  
 
To seed a certain amount of cells for experiments, cell counting using hemocytometer was 
used. The hemocytometer and glass coverslip were first cleaned with 70 % ethanol. The 
coverslip was placed over the hemocytometer surface at a height of 0.1 mm so that the total 
volume for each of the nine 1 mm
2
 squares of the counting grid is 0.1 mm
3
. After 
trypsinization, one drop of cell suspension was introduced into one of the V-shaped wells 
with a micropipette and the area under the coverslip was filled by cell suspension due to 
capillary action. The hemocytometer was then placed on a microscope stage and the counting 
grid was observed under 10X objective using a brightfield microscope. The cells in the four 
corner squares were counted. Only the cells on the top and left-hand sides of each square 
were included to avoid bias. Cell concentration was calculated as follows: 





5.2.3 Preparation of DENV2 virus stock 
 
The virus used was Dengue virus serotype 2 (DENV2, New Guinea C strain) which was 
propagated on C6/36 cells. The cell culture medium was discarded and the cell monolayer 
was rinsed with 5 mL of PBS. Multiplicity of Infection (M.O.I.) of 10 was used. 1 mL of 
virus suspension was used for the infection of cell monolayer in a 75cm
2
 flask. The flask was 
incubated at 37 
o
C for 1 h and rocked every 15 min to ensure even infection of the whole 
flask. After 1 h, 14 mL of maintenance medium was added to the flask. The cells were 
incubated at 28 
o
C until the cytopathic effects of the respective cell lines became pronounced. 
DENV2 was harvested after 4 days of incubation, when syncytial formation on C6/36 cells 
was completed. To harvest the viruses, the extracellular virus-containing supernatants were 
collected and spun at 1500 rpm for 10 minutes to remove cellular debris. The virus 




5.2.4 Plaque Assay  
 
The amount of viruses harvested was determined and the virus titer, which is the 
concentration of infectious viral particles, was calculated. Ten-fold serial dilutions of the 
DENV2 samples up to the dilution factor of 10
-6 
were prepared in maintenance media of 
RPMI 2 % FBS. Aliquots of 100 μL from the appropriate dilutions were inoculated in 
triplicates onto monolayers of confluent BHK-21 cells grown in sterile 24-well tissue culture 
plate (plated at 62,500 cells/well). The virus-inoculated monolayers were incubated for 1 h at 
37 
o
C and rocked every 15 min to ensure even distribution of virus inocula. After 1 h of 
incubation, the inocula were removed upon washing thrice with PBS. 1 mL of semi-solid 
medium, 2 % carboxymethylcellulose (CMC) in cell culture medium containing 2 % FBS, 
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was then layered onto the virus-infected cell monolayers. The plates were incubated at 37 
o
C 
in a humidified incubator with 5 % carbon dioxide for five days. After incubation, circular 
zones of infected cells called plaques were formed. Plaques were visualized by staining the 
cell monolayer with 0.5 % crystal violet solution overnight at room temperature. Plaques 
were counted and only wells in the range of between 10 and 100 plaques were accounted for 
in order to minimize error. Number of plaques counted, in combination with the dilution 
factor from which the plaques were counted were used to calculate the virus titer, expressed 
as plaque-forming units per millilitre (PFU/mL). PFU values indicate the number of 
infectious virus particles for a particular sample with an assumption that a single plaque 
represents an infectious virus particle. 
 
5.2.5 NIR light attenuation study 
 
A black box was used for this study (Figure 5.1). Holes were created at two opposite sides 
large enough to hold the 980 nm VD-IIIA DPSS NIR laser driver (Photonitech, Singapore) 
and NIR detector (model no. NIR512, Ocean Optics, USA). The NIR detector was connected 
to a computer installed with Spectrasuite software (Ocean Optics, USA) for recording of NIR 
intensity. A cuvette was placed at the centre of the box and a cuvette holder made from 
polystyrene was used to hold the cuvette firmly on its ground. NIR filter was sticked to the 
cuvette’s surface at the side facing the NIR detector. 3 mL of sample solution was added into 
the cuvette and irradiated at a certain laser power. The NIR light that passed through the 
solution was detected by NIR detector. The NIR intensity between 950 nm and 1000 nm was 
recorded by Spectrasuite software (Ocean Optics, USA). To measure the NIR intensity of 
sample solution in the presence of tissues, mouse skin tissues of 1 mm thick from the mice’s 
back of female C57BL/6 mice, 4 – 6 weeks old were used. The thickness of the skin tissues 
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was measured with vernier caliper in order to ensure that the skin tissues used were of 
uniformly 1 mm thick. 3 different tissue thicknesses at 1, 5, and 10 mm were tested. For 
tissue thickness of 5 mm, 5 pieces of mouse skin tissues, each at 1 mm thick were stacked 
together and the same applied to tissue thickness of 10 mm with 10 pieces of 1 mm thick 
mouse skin tissues. The tissues were stuck to the cuvette at the side facing the NIR laser 
driver. The sample in the presence of tissues was irradiated by NIR laser at a certain laser 
power. The NIR light that passed through the tissues and the solution was detected by NIR 
detector and the NIR intensity between 950 nm and 1000 nm was recorded. The samples 
tested and experimental conditions used in this study were shown in Table 5.1.       
 









Sample Laser Power 
DI water 
Without mouse tissue 
Each sample was irradiated 
with five different laser 
powers at 68.7, 470, 660, 858 
and 1150 mW 
L15 medium 
L15 + ZnPc-MS-UCN 
L15 + ZnPc-MS-UCN + DENV2 
L15 + ZnPc-MS-UCN + DENV2 
With mouse tissue 
(Thickness: 1 mm) 
L15 + ZnPc-MS-UCN + DENV2 
With mouse tissue 
(Thickness: 5 mm) 
L15 + ZnPc-MS-UCN + DENV2 
With mouse tissue 
(Thickness: 10 mm) 
Table 5.1 Experimental conditions for NIR light attenuation study. The concentration of 
ZnPc-MS-UCN was 1 mg/mL and DENV2 titer was 2.59 x10
7
 PFU/mL.  
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5.2.6 NIR light photodamage to DENV2 
 
200 µL DENV2 (7.41 log10 PFU/mL) was irradiated with NIR light at 980 nm VD-IIIA 
DPSS NIR laser driver in a 96-well tissue culture plate. Different light fluences of 20, 40, 80 
and 160 kJ/cm
2
 were tested and the distance between the light source and the viral samples 
was set at 5 cm. Another similar set of samples were prepared as dark controls, they were not 
subjected to NIR irradiation but kept in the dark for the same duration as the NIR irradiation 
time of the light-treated samples. Virus titers of all the samples were determined by plaque 
assay as described in Section 5.2.4.  
 
5.2.7 Photodynamic inactivation of DENV2 in suspension  
 
200 μL of DENV2 (7.41 log10 PFU/mL) in L15 medium were mixed with a range of ZnPc-
MS-UCN concentrations (0, 100, 500, 750, 1000, 1250, 1500, 2000 µg/mL) in a 96-well 
tissue culture plate under aseptic conditions. These samples were irradiated with NIR light at 
980 nm using VD-IIIA DPSS NIR Laser Driver at the fluence of 20 kJ/cm
2
 (with laser power 
of 0.47 W and irradiation time of 14 min 11 sec) with the distance between the light source 
and the viral samples fixed at 5 cm. A similar set of samples were also prepared and they 
were kept in the dark for the same duration as the NIR irradiation time of the light-treated 
samples. Virus titers of the light-treated and dark control samples were determined via plaque 
assay as described in Section 5.2.4.  
 
In another study, 200 μL of DENV2 (7.41 log10 PFU/mL) in L15 medium were mixed with 
0.5 mg/mL ZnPc-UCNs in a 96-well tissue culture plate under aseptic conditions. The 
samples were exposed to NIR irradiation at 980 nm using VD-IIIA DPSS NIR laser driver at 
different light fluences (20, 30, 40, 50, 60 kJ/cm
2
). The laser power was fixed at 0.47 W and 
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various irradiation time depending on the light fluences were used (Table 5.2). The distance 
between the light source and the viral samples was fixed at 5 cm. Another similar set of 
samples were prepared but they were kept in the dark for the same duration as the NIR 
irradiation time of the light-treated samples. Virus titers of the light-treated and dark control 
samples were determined via plaque assay as described in Section 5.2.4.       
Light fluence (kJ/cm
2
) Irradiation time 
20 14 min 11 sec 
30 21 min 17 sec 
40 28 min 22 sec 
50 35 min 28 sec 
60 42 min 33 sec 
Table 5.2 Experimental conditions for photodynamic inactivation of viruses at different light 
fluences and the associated irradiation time. 
 
For both the studies, reduction in virus titers was obtained by subtracting the virus titers of 
the NIR light-treated samples from the virus titers of their associated dark controls. 
Photodynamic inactivation efficacy was assessed based on percentage reduction of virus titer. 










of virus titer (%) 
Virus titer of 
dark control 
sample (Light -) 
Virus titer of dark control sample 
(Light -) 
Virus titer of 
light-treated 
sample (Light +) 
_ 
x 100 % = 
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5.2.8 Photodynamic inactivation of DENV2 in the presence of mouse 
tissues 
 
200 μL of DENV2 (7.41 log10 PFU/mL) in L15 medium were mixed with a range of ZnPc-
MS-UCN concentrations (0, 100, 500, 750, 1000, 1250, 1500, 2000 µg/mL) in a 96-well 
tissue culture plate under aseptic conditions. The wells were covered with mouse skin tissues 
of 5 mm thick (Figure 5.2). This was achieved by stacking 5 pieces of 1 mm thick mouse skin 
tissues as described in Section 5.2.5. These samples were then irradiated with NIR light at 
980 nm using VD-IIIA DPSS NIR Laser Driver at the fluence of 40 kJ/cm
2
 (with laser power 
of 0.284 W and irradiation time of 46 min 57 sec) and the distance between the light source 
and the viral samples was fixed at 5 cm. A similar set of samples were also prepared and they 
were kept in the dark covered with 5 mm mouse skin tissues for the same duration as the NIR 
irradiation time of the light-treated samples. Virus titers of the light-treated and dark control 
samples were determined via plaque assay as described in Section 5.2.4. Reduction in virus 
titers was obtained by subtracting the virus titers of the NIR light-treated samples from the 
virus titers of their associated dark controls. Photodynamic inactivation efficacy was assessed 






Figure 5.2 Experimental design for photodynamic inactivation of DENV2 in suspension 





5.3 Results and Discussion 
 
5.3.1 NIR light attenuation of DENV2, UCNs and cell culture medium 
 
A light attenuation study was done to investigate any possible interference the different 
components of a sample have on NIR light propagation. The interference could be due to 
absorption or scattering of the NIR light by the components of a sample which in turn reduces 
the energy to excite the photosensitizers and subsequently weaken the photodynamic 
inactivation efficacy. A typical sample consists of DENV2 and ZnPc-MS-UCNs in L15 cell 
culture medium. A sample containing only L15 medium was tested for the NIR light 
attenuation before nanoparticles and DENV2 were being added subsequently. A DI water 
sample was introduced as a control. Five laser powers from lower to higher ends were used in 
this study. As shown in Figure 5.3, only one intensity peak at 980 nm was obtained which is 
in accordance with the NIR laser driver designed to emit NIR light at the wavelength of 980 
nm. NIR intensities of L15 medium, L15 medium with nanoparticles and L15 medium 
containing nanoparticles and DENV2 remained stable for all five laser powers tested. All the 
samples including DI water displayed similar intensities when they were exposed to NIR 
irradiation. It can be concluded from this study that NIR light was not attenuated by 
components of a typical sample used for photodynamic inactivation experiments and the light 
energy delivered to the sample remained stable.      
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Figure 5.3 NIR intensities that passed through different components in a typical sample used 
for photodynamic inactivation experiments. DI water was used as a control. 
 
5.3.2 Background study on NIR light photodamage to DENV2 
 
Before commencing the studies on the photodynamic inactivation efficacy of ZnPc-MS-
UCNs, it was imperative to examine NIR light photodamage to viruses. Light irradiation 
normally produces heat and high light fluence increases the amount of heat produced. Thus, 
photodamage to viruses could occur if high light fluence is used. This study was also crucial 
in determining suitable light fluences to be used for subsequent photodynamic inactivation 
experiments. A suitable light fluence should not cause any significant damage and drastic 
reduction of virus titers. This was to rule out the photodamage effect and to ensure that any 
reduction in virus titers observed was due to the photodynamic action of the nanoparticles. In 
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this study, DENV2 suspension was exposed to NIR irradiation at different light doses and the 
extent of light photodamage was measured based on the virus titers determined by plaque 
assay.  
 
Based on the results, NIR light photodamage to viruses increased with light fluence (Figure 
5.4). The highest virus titer reduction was observed when DENV2 was irradiated at the 
fluence of 160 kJ/cm
2
. At this fluence, DENV2 titer decreased by 2.12 log10 PFU/mL 
compared to the dark control for the same fluence. 1.3 log10 PFU/mL reduction was recorded 
when DENV2 was irradiated at the fluence of 80 kJ/cm
2
 while less than 1 log10 PFU/mL 
reduction in virus titers were obtained for 20 and 40 kJ/cm
2
. The reduction in virus titers 
compared to dark controls was statistically significant (P < 0.05) for DENV2 irradiated at 
fluences of 80 and 160 kJ/cm
2
. Less than 5 % reduction was observed when fluence of 20 
kJ/cm
2
 was used to irradiate DENV2 while around 10 and 20 % reduction in virus titers were 
observed for 40 and 80 kJ/cm
2
 (Figure 5.5). The highest percentage reduction of 32 % was 
observed for the fluence of 160 kJ/cm
2
. Based on this study, light fluences up to 40 kJ/cm
2
 
could be used for subsequent photodynamic inactivation experiments as the the reduction in 
virus titers was statistically insignificant and the effect of photodamage to DENV2 was 




Figure 5.4 Infectious virus titers of DENV2 irradiated with different light fluences. All 
experiments were performed in triplicate and error bars represent standard deviations of the 
mean. Statistical analysis was done by comparing light-treated samples to their respective 
dark controls using Student’s t-test, * P < 0.05. 
 
 
Figure 5.5 Percentage reduction of virus titer for DENV2 irradiated with different light 
fluences. Error bars represent standard deviations of the mean. Statistical analysis was done 
by comparing each of the DENV2 samples irradiated with 40, 80 and 160 kJ/cm
2
 to the 
DENV2 sample irradiated with 20 kJ/cm
2




















































































5.3.3 Photodynamic inactivation of DENV2 in suspension with various 
concentrations of ZnPc-UCNs 
 
We first examined the effect of nanoparticle concentrations on the photodynamic inactivation 
efficacy of this UCN-based system. Based on the previous light photodamage study, light 
fluence of 20 kJ/cm
2
 caused negligible photodamage effect to viruses and was chosen as the 
light fluence for this study. DENV2 in L15 cell culture medium was mixed with various 
concentrations of ZnPc-MS-UCNs and irradiated at a fixed light dose of 20 kJ/cm
2
. Another 
similar set of samples which acted as dark controls was prepared and kept in the dark without 
NIR irradiation. The results demonstrated that reduction in virus titers was concentration-
dependent (Figure 5.6). Sample with the lowest nanoparticle concentration at 100 µg/mL was 
the least effective to photodynamically inactivate DENV2. At this concentration, the virus 
titer of the light-treated sample was 6.45 log10 PFU/mL, a 0.68 log10 PFU/mL or 9.6 % 
reduction (Figure 5.7) from its respective dark control sample. This reduction was just mildly 
lower than samples containing solely of DENV2 without any nanoparticle added (0 µg/mL). 
For this experimental set, the light-treated sample showed a reduction of 0.27 log10 PFU/mL 
when compared to its associated dark control sample. Significant virus titer reduction (P < 
0.05) was seen for concentrations at 500 µg/mL and above. Virus titers reduced by more than 
half (52 % or 3.73 log10 PFU/mL reduction) when nanoparticle concentration of 500 µg/mL 
was used and further reduction of virus titer was recorded for nanoparticle concentration of 
750 µg/mL which showed 5.66 log10 PFU/mL or 80 % reduction in virus titers compared to 
the same concentration in the dark. The best photodynamic inactivation efficacy was 
achieved when nanoparticles at the concentrations of 1000 µg/mL and onwards were used to 
intivate the viruses. Complete virus inactivation was observed for samples at 1000, 1250, 
1500 and 2000 µg/mL of ZnPc-MS-UCNs, giving a 100 % reduction in virus titers. 
Meanwhile, for lower nanoparticle concentrations (100, 500, 750 and 1000 µg/mL ), the virus 
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titers of their dark control samples remained stable and having around the same virus titer 
with the 0 µg/mL sample which only contained DENV2.  
 
The virus titers of the dark control samples started to decrease when higher nanoparticle 
concentrations of 1250, 1500 and 2000 µg/mL were used. Compared to the DENV2 titer of 0 
µg/mL at 7.12 log10 PFU/mL, these three concentrations of 1250, 1500 and 2000 µg/mL 
nanoparticles caused a much reduced titers at 5.58 log10 PFU/mL, 4.63 log10 PFU/mL and 
2.45 log10 PFU/mL respectively. Compared to 0 µg/mL, 65 % reduction in virus titer, which 
was the sharpest decrease, was obtained when the highest nanoparticle concentration of 2000 
µg/mL was used. The significant reduction in virus titers for dark control samples of higher 
nanoparticle concentrations was due to the toxicity of nanoparticles which echoed the same 
observation for the PEI-coated nanoparticles that caused complete virus inactivation at 
nanoparticle concentration of 2200 µg/mL. Although nanoparticle toxicity could also 
contribute to virus inactivation, it could possibly damage healthy cells or tissues if high 
amount of nanoparticles are to be used to treat localized tissue infections.    
 
Overall, photodynamic inactivation efficacy increased with higher ZnPc-MS-UCN 
concentrations. High amount of nanoparticles was toxic to viruses. Taking the nanoparticle 
toxicity into account, ZnPc-UCN concentration of 1000 µg/mL produced the best 




Figure 5.6 Infectious virus titers of DENV2 mixed with different ZnPc-MS-UCN 
concentrations and irradiated with 980 nm NIR light at the fluence of 20 kJ/cm
2
. Nanoparticle 
toxicity was observed for ZnPc-MS-UCN concentrations of 1250 µg/mL and above. All 
experiments were performed in triplicate and error bars represent standard deviations of the 
mean. Statistical analysis was done by comparing light-treated samples to their respective 
dark controls using Student’s t-test, * P < 0.05. 
 
 
Figure 5.7 Percentage reduction of virus titer for DENV2 mixed with different   
concentrations of ZnPc-MS-UCN and irradiated with 980 nm NIR light at the fluence of 20 
kJ/cm
2
. Error bars represent standard deviations of the mean. Statistical analysis was done by 
comparing each of the samples to the control, 0 µg/mL (DENV2-only sample), using 
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5.3.4 Photodynamic inactivation of DENV2 in suspension with different 
light fluences 
 
Apart from concentration of nanoparticles, we further studied the effect of light fluence on 
the photodynamic inactivation efficacy of these nanoparticles. By fixing laser power, higher 
light fluence can be achieved by increasing the irradiation time, thus increasing the energy 
delivered to the irradiation site as well. Different light fluences were used in this study so as 
to explore the relationship between light fluence and photodynamic inactivation efficacy of 
the nanoparticles. Similar to the concentration of nanoparticles, the results demonstrated that 
photodynamic inactivation ability of ZnPc-MS-UCNs was light fluence-dependent. Virus 
titers of the light-treated samples reduced steadily from 3.44 log10 PFU/mL to 1.81 log10 
PFU/mL upon NIR irradiation with light fluences ranging from 20 to 60 kJ/cm
2
 (Figure 5.8). 
The percentage reduction of virus titers was further increased from 52 % at 20 kJ/cm
2
 to 74 % 
at 60 kJ/cm
2
, giving a 20 % more reduction in virus titers (Figure 5.9). By fixing the 
nanoparticle concentration at 500 µg/mL, photodynamic inactivation efficacy can be 
improved by delivering higher light fluence to the nanoparticles. Thus, effective 
photodynamic inactivation condition can be achieved by tuning the combination of 
nanoparticle concentrations and light doses while keeping the toxicity of nanoparticles and 






Figure 5.8 Infectious virus titers of DENV2 mixed with 0.5 mg/mL ZnPc-MS-UCNs and 
irradiated with 980 nm NIR light at different light fluences. All experiments were performed 
in triplicate and error bars represent standard deviations of the mean. 
 
Figure 5.9 Percentage reduction of virus titer for DENV2 mixed with 0.5 mg/mL ZnPc-MS-
UCNs and irradiated with 980 nm NIR light at different light fluences. Error bars represent 

















































































5.3.5     Photodynamic inactivation of viruses in a tissue model 
 
5.3.5.1 NIR light attenuation of mouse tissue  
 
Previous light attenuation study (as described in Section 5.3.1) had shown that NIR light was 
not attenuated by components of a typical sample used for photodynamic inactivation 
experiments. We further this light attenuation studies to investigate the tissue penetration 
depth of the NIR light. Mouse skin tissues of three different thicknesses were used for the 
study and the experimental design and procedures were described in Section 5.2.5. A control 
sample of DENV2 and ZnPc-MS-UCNs in L15 medium exposing to NIR irradiation without 
the mouse skin tissues was used for comparison. For all three tissue thicknesses, the NIR 
intensity reduced when the samples were irradiated with five different laser powers. (Figure 
5.10). Light attenuation was not observed for the control sample. Higher intensity was 
observed when stronger laser power was used, suggesting that light-tissue penetration is laser 
power-dependent. This was to be expected as higher laser powers with more intense energy 
can penetrate deeper into the tissue than lower laser powers. Compared to the control sample, 
the percentage reduction of NIR intensity for sample with 1 mm tissue thickness was between 
33 – 48 %, further increased to between 72 – 83 % for sample with 5mm tissue thickness and 
recorded a reduction of between 91 – 97 % for sample with 10 mm tissue thickness (Figure 
5.11). Depending on the tissue thickness, the NIR light has shown the ability to penetrate 
mouse skin tissues. The NIR light can penetrate 1 and 5 mm thick tissues and even to the 
extent of 10 mm tissue depth albeit with much lower intensity. NIR light has been shown to 
have better tissue penetration ability than visible light. Visible light at 410 nm has been 
reported to penetrate only 1 to 2 mm into skin and increases up to 6 mm at 635 nm [74]. 
Studies to measure the penetration depth of various human tissues have shown that NIR light 
is able to penetrate deeper than red light for all measured tissues [75]. The observation that 
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the NIR intensity decreased with increasing tissue thickness could be attributed to the 
scattering and internal reflection properties of the tissues which could reduce the amount of 
light to be delivered to the target [76].             
 
 
Figure 5.10 NIR intensities of samples (DENV2 and ZnPc-MS-UCNs in L15 medium) 




Figure 5.11 Percentage reduction of NIR intensity for samples beneath mouse tissues of 
different thicknesses. Error bars represent standard deviations of the mean. All experiments 
were performed in triplicate and error bars represent standard deviations of the mean. 
 
5.3.5.2   Photodynamic inactivation of DENV2 beneath the mouse tissues 
 
A preliminary study was performed to investigate the possibility of inactivating viruses 
photodynamically beneath the tissues. As tissues were involved in this study, a skin charring 
test was done to determine a suitable range of laser powers to be used in order to avoid 
burning, charring or any damage to the skin tissues due to high powers and long-term 
irradiation.  In this test, female C57BL/6 mice was irradiated with 980 nm NIR light 
continuously for 1 h using laser powers in the range of 145 – 638 mW. At any one time, each 
mouse was irradiated with a fixed laser power for 1 h and the mice were observed for skin 
charring post laser treatment. After irradiation, laser power above 294 nm was shown to 
cause skin charring while laser power range of 145 – 294 mW did not show any skin charring 



















Table 5.3 Post laser treatment skin charring observation of C57BL/6 mice irradiated for 1 h 
at different laser power. (Courtesy of Ms. Niagara Muhammad Idris) 
 
Laser power of 284 mW (0.284 W), which falls in the range of 145 – 294 mW was used for 
the subsequent photodynamic inactivation study. Mouse skin tissues of 5 mm thick was used 
to cover wells which contained DENV2 in L15 medium added with ZnPc-MS-UCNs of 
different concentrations in a 96-well tissue culture plate. The experimental set-up and 
procedures were described in Section 5.2.8. Concentration-dependent reduction of virus titers 
























tissues (Figure 5.12). These results were consistent with the photodynamic inactivation of 
DENV2 in suspension (Section 5.3.3). However, the photodynamic inactivation efficacy in 
the presence of mouse skin tissues was generally lower in comparison with the efficacy of 
samples in suspension without tissues. Upon comparing with their respective dark control 
samples, less than 2 log10 PFU/mL reductions were observed for nanoparticle concentrations 
of 100, 500 and 750 µg/mL with percentage reduction of 14.7, 15.9 and 24.8 % respectively 
(Figure 5.13). Significant reduction in virus titers was only observed for nanoparticle 
concentration of 1000 µg/mL and above. A reduction range of 3.02 – 4.18 log10 PFU/mL (42 
– 90 % reduction) from their associated dark control samples was obtained for ZnPc-MS-
UCN concentrations of 1000, 1250 and 1500 µg/mL. Complete virus inactivation was 
achieved for sample with the highest nanoparticle concentration of 2000 µg/mL ZnPc-MS-
UCNs, giving a 100 % reduction. 
 
For ZnPc-UCN concentrations of 1250, 1500 and 2000 µg/mL, the virus titers of their dark 
control samples (Light -) showed that the nanoparticles were toxic to DENV2 at these 
concentrations. Compared to the virus titer of 0 µg/mL dark control sample which contained 
only DENV2 (7.12 log10 PFU/mL), the virus titers of these three concentrations decreased 
drastically to 5.48 log10 PFU/mL, 4.63 log10 PFU/mL and 2.32 log10 PFU/mL respectively. 
 
This study has shown the ability of NIR light to penetrate mouse skin tissues at 5 mm and 
photodynamically inactivate DENV2 beneath the tissues. Nevertheless, with increasing 
nanoparticle concentrations, virus titers were reduced significantly. ZnPc-MS-UCN 
concentration of 1000 µg/mL gave the best photodynamic inactivation efficacy without 





Figure 5.12 Infectious virus titers of DENV2 mixed with different ZnPc-MS-UCN 
concentrations beneath 5 mm thick mouse skin tissues and irradiated with 980 nm NIR light 
at the fluence of 40 kJ/cm
2
. All experiments were performed in triplicate and error bars 
represent standard deviations of the mean. Statistical analysis was done by comparing light-
treated samples to their respective dark controls using Student’s t-test, * P < 0.05. 
 
Figure 5.13 Percentage reduction of virus titers for DENV2 in different ZnPc-MS-UCN 
concentrations beneath 5 mm thick mouse skin tissues and irradiated at 980 nm NIR light at 
the fluence of 40 kJ/cm
2
. Error bars represent standard deviations of the mean. Statistical 
analysis was done by comparing each of the samples to the control, 0 µg/mL (DENV2-only 
























































































Upon NIR irradiation at 980 nm, the ZnPc-loaded mesoporous silica-coated nanoparticles 
photodynamically inactivated DENV2 in suspension in concentration- and light dose-
dependent manners. NIR light at 980 nm was able to penetrate mouse skin tissues of 5 mm 
and inactivated the DENV2 in suspension beneath the tissues. Higher concentrations of 
nanoparticles were toxic to viruses, which may also toxic to cells and tissues. The 
combination of nanoparticle concentration and light fluence can be further optimized to 
achieve effective photodynamic inactivation with minimal or no toxicity caused to the 




Chapter 6: Conclusions and future work 
6.1 Main conclusions 
 
We report here a novel antiviral approach to inactivate viruses via UCN-based photodynamic 
inactivation strategy. This is the first report of such inactivation strategy to be shown against 
viruses. The feasibility of this strategy was first displayed by the photodynamic inactivation 
of DENV2 in suspension by ZnPc-PEI-UCNs and was shown to be nanoparticle 
concentration-dependent.  
 
The nanoparticle design of ZnPc-PEI-UCN was relooked and an improved version of UCNs 
in the form of mesoporous silica-coated UCNs were synthesized. These nanoparticles were 
characterized to possess porous silica structures to store photosensitizers. ZnPc 
photosensitizers were loaded into the pores of mesoporous silica using the ZnPc loading 
concentration showing the best singlet oxygen profile. The porous structures of silica allow 
the release of singlet oxygen from the nanoparticles to the surroundings with ease. Most 
importantly, the hydrophobic ZnPc photosensitizers remain strongly in the pores when 
incubated in aqueous solutions. Moreover, the porous silica protects photosensitizers from 
being degraded in the harsh biological environment.  
 
Similar to the ZnPc-PEI-UCNs, the ZnPc-Si-UCNs photodynamically inactivated DENV2 in 
suspension in a concentration-dependent manner. In addition, the photodynamic inactivation 
was shown to be light dosage-dependent also. NIR light at 980 nm was shown to penetrate 5 
mm thick mouse skin tissues and inactivated the DENV2 in suspension beneath the tissue. 
This signifies the advantages of using NIR-to-visible UCNs which get excited by NIR light 
that possesses high light penetration depth in vivo and emit visible radiations necessary to 
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excite the photosensitizers. In view of nanoparticle toxicity to viruses at higher 
concentrations, which may also toxic to cells and tissues, optimization of various parameters 
can be done to achieve effective photodynamic inactivation of viruses using optimum light 
dose and lower concentration of nanoparticles with minimal or no toxicity caused to the 
healthy cells and tissues.  
6.2 Recommendations for future work 
 
The feasibility of using UCNs for photodynamic inactivation of viruses has thus far been 
shown in cell culture suspension using Dengue virus as a model. Since this UCN-based 
system has been proven feasible to inactivate Dengue virus, the similar studies can be further 
applied to viruses causing localized infections such as herpesvirus and papillomavirus to 
provide a more realistic assessment of this system. In addition, this strategy can be further 
extended to study the photodynamic inactivation in virus-infected cellular system. As the 
cells have been infected by viruses, attempts should be made to remove intracellular viruses 
through direct killing of the infected cells as well as inactivate the extracellular viruses which 
are being released from cells into the cell culture medium. Internalization of ZnPc-loaded 
nanoparticles can first be done by incubating the nanoparticles with the infected cells before 
the cells were exposed to NIR irradiation. The PDT efficacy can then be evaluated by 
measuring cell viability and virus titer reduction via MTT assay and plaque assay 
respectively. MTT assay measures the percentage of surviving infected cells after PDT 
treatment while plaque assay measures infectious virus titer from the collected cell culture 
medium. The nanoparticles have been shown to be toxic to viruses at higher concentrations 
which raised concern about its toxicity to cells as well. To assess the nanoparticle toxicity, 
UCNs can be incubated in the dark with cells of interest at different nanoparticle 
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concentrations for a certain period of time and the cell viability can subsequnetly be 
measured via MTT assay.  
 
On the other hand, a quantitative in vivo tissue penetration depth studies are needed to 
measure the extent of penetration distance and light energy that presents under the skin. The 
photodynamic inactivation of viruses beneath the tissues can be further studied by using 
different tissue thicknesses. To provide a more realistic assessment concerning the feasibility 
of UCN-based strategy in treating viruses beneath the tissues, a mouse model with localized 
virus infections should be created. The ZnPc-loaded nanoparticles at certain concentrations 
will then be injected directly to the localized infections site and the localized infected area 
will be exposed to NIR irradiation after a certain period of incubation time. Tissues will later 
be homogenized and virus titers determined via plaque assay.  
 
Meanwhile, further investigation could also be performed to elucidate the underlying 
mechanism which causes the inactivation of viruses. Although Type II reaction which 
produces singlet oxygen is widely seen as the dominant reaction that mediates the 
photodynamic inactivation of viruses, the type I reaction which produces superoxides and 
hydroxyls may co-exist together with Type II reaction and contributes toward virus 
inactivation. The photodynamic inactivation effect on viral replication ability is also another 
important aspect to look into. Due to photodynamic damage, the viruses may either loss the 
ability to replicate in the host cells or incapable to recognize and bind to the host cells which 
significantly reduces the propagation and spread of viruses. In addition, the photodynamic 
inactivation damage to viral genome and envelope protein could also be examined. The 
knowledge that we gain from the photodynamic inactivation mechanism will greatly aid in 
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